WO2013082978A1 - Immunization procedure graph and building method therefor and inoculation information processing method and system - Google Patents

Immunization procedure graph and building method therefor and inoculation information processing method and system Download PDF

Info

Publication number
WO2013082978A1
WO2013082978A1 PCT/CN2012/083567 CN2012083567W WO2013082978A1 WO 2013082978 A1 WO2013082978 A1 WO 2013082978A1 CN 2012083567 W CN2012083567 W CN 2012083567W WO 2013082978 A1 WO2013082978 A1 WO 2013082978A1
Authority
WO
WIPO (PCT)
Prior art keywords
vaccination
node
vaccine
program
immune
Prior art date
Application number
PCT/CN2012/083567
Other languages
French (fr)
Chinese (zh)
Inventor
吴卫民
Original Assignee
Wu Weimin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wu Weimin filed Critical Wu Weimin
Publication of WO2013082978A1 publication Critical patent/WO2013082978A1/en

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Definitions

  • the invention belongs to the field of computer software, and in particular relates to an immune program diagram and a method for establishing the same, and a method and system for processing the seeding information. Background technique
  • a vaccine is a biological product that stimulates the body's immunity to disease, thereby preventing or reducing the effects of disease pathogen infection.
  • the description of the vaccine product gives a method for the use of a vaccine based on clinical analysis studies, usually through multiple doses of vaccination to achieve the best preventive effect.
  • immunization There are still some situations in the implementation of immunization that are not covered in the instructions for the vaccine product, but they must be handled correctly. For example, simultaneous and isochronous vaccination of different vaccines; selection of vaccination time for multiple or multiple attenuated inactivated vaccinations.
  • the National Center for Disease Control and Prevention is responsible for formulating rules related to immunization. In addition to the regulations on the use of vaccine products, the rules also provide some treatments for the actual implementation of immunization.
  • the immunization program is an immunization implementation method based on this rule.
  • a computer program is needed to interpret the immunization program and automatically analyze and process data related to immunization, such as assessing a person's immunization history and recommending the immunizations required for this person in the future.
  • This computer program should also include some of the decision-making functions of the immunization practitioner, such as those directly related to the immunization program; updating and using the latest version of the immunization program; and selecting the appropriate version of the immunization program when processing historical data.
  • another object of the present invention is to provide a method and system that can be used for immunological program visualization establishment and maintenance methods and systems, as well as for processing vaccination information Immune program map.
  • the technical solution of the invention is as follows - an immunological program diagram comprising a plurality of nodes and a plurality of vector lines,
  • one of said nodes represents a dose of vaccination of the immunization program and its attributes, said attributes including conditional information for vaccination of the dose;
  • the following data structure is used to store information about a node of the immune program map and its subsequent nodes and can be processed with dry vaccination information:
  • the data structure includes the following data elements: (1) an identifier (201) that uniquely identifies the node, (2) a dose of agent information (202) corresponding to the node, and (3) The next inoculation of the inoculation is followed by information on the subsequent node information (203).
  • the agent information includes a set of constraints.
  • the vaccine constraint in the constraint is information on the meta-vaccine.
  • the constraint includes a constraint of a valid date range (221) of a node.
  • the subsequent node information (203) includes priority information for each subsequent node.
  • a method of generating and maintaining an immune program for use in vaccination information processing organized by an immunological program providing a graphical user interface on a computer to enable a user to establish and maintain the aforementioned immune program map, including;
  • the user interface includes a dynamic menu and toolbar generation and management module based on an immune program related object for generating and managing a task menu and a toolbar based on the selected immune program related object. To guide, build, maintain, and manage immune program maps.
  • the user interface also includes an immune program assisted design task module for automatically generating and completing, self-consistent inspection and maintenance of interrelated data in the immune program map.
  • the immune program assisted design task module includes the task of generating a meta-vaccine by a vaccine.
  • the immune program assisted design task module includes the task of generating a vaccine or meta-vaccine immune program map framework from a vaccine or meta-vaccine.
  • the immune program assisted design task module includes a task of analyzing constraint overlap between subsequent nodes of a node
  • the criterion for judging that the two node constraints do not overlap is: comparing the range of parameter values of the same constraint of the two nodes. If there are two nodes with the same constraint, the parameter values are completely repulsive, then the two knots The points do not overlap.
  • the method of generating and maintaining an immune program organized by the immune program map for processing the vaccination information further includes issuing an immune program map on the computer for establishing and maintaining.
  • the immune program map established and maintained by the distribution refers to the release of the immune program map in a graphic format, including:
  • a legend is used to illustrate the meaning of symbols, characters, strings, and graphic elements in the immune block diagram.
  • a method of processing vaccination information wherein the immunization program is based on the aforementioned immunological program map, and the information about the vaccine of the immunization schedule is meta-vaccine information, the method comprising the steps of:
  • Each injection in the vaccination history of the vaccinator is converted into a vaccination injection and stored in the vaccination history (1124);
  • the processing method for the system in the step of evaluating the recommendation process is - a) initializing the subsequent node set (1125), assigning the set of all the initial nodes of the system to the subsequent node set;
  • the recommendation of a series of future vaccination refers to determining the future vaccination of a line within the recommended date range [T staii , U, and recommending that the future vaccination of the line does not require the end of the system's immune program map or although the system is used
  • the recommending a future vaccination refers to determining a future vaccination on a recommended date, I [T startJ T e; id ] ⁇ It is recommended that the future inoculation of the line be 3 ⁇ 4 to the end of the line's immunization map, which includes the optional inoculation constraint, the step is - first check if the optional inoculation constraint is met; , then continue the recommendation process according to the endpoint without the optional vaccination constraint; otherwise, the vaccination of the system has been completed, and one method of processing the system in the system-by-system evaluation process is : If the line has a cut-off age, the agent checks whether the age of the vaccinator has exceeded the cut-off age before the evaluation process, and exits the treatment of the line if it exceeds; otherwise, the evaluation and recommended treatment of the line are continued.
  • One method for the one-line evaluation of the treatment in the recommendation process is: if the system has a deadline for the system, and after the evaluation is completed, the vaccination procedure is not completed, then the test is performed before the recommendation process Whether the age of the vaccinator has exceeded the cut-off age, and if it exceeds, the treatment of the system is withdrawn; otherwise, the recommended treatment of the system is continued.
  • a system comprising: means for performing the steps of the foregoing method.
  • the foregoing methods are: ⁇ ) - a method of generating and maintaining an immune program organized by an immunological program for use in vaccination information processing, and (2) a method of processing vaccination information.
  • the present invention provides a method and system for establishing and maintaining an ISG.
  • the user can graphically and intuitively design, edit, and view the relationship between the nodes corresponding to the ISG doses on the computer, and input and edit. Manage ISG data.
  • the introduction of the system also simplifies the dependence of each dose of the combination vaccine, facilitating the design, maintenance and operation of the ISG.
  • the present invention provides a method and system for processing vaccination information using BG. The high availability performance of this system is improved because the method described above reduces the time required for the immune program to change the response to the system in which the vaccination information is processed.
  • the introduction of the system also makes it easier to design and maintain software that processes the vaccinator information method, thereby making the system for processing vaccinator information easier to maintain.
  • the user can process the vaccinator information by ffl, a system that causes the ffl ISG to represent the immunization program.
  • the present invention organically integrates various vaccination-related data involved in the immunization program to provide an easy-to-use data platform and system for medical institutions or individual users.
  • the data platform and system can be used for users.
  • Figure 2 is a block diagram showing a method for visualizing an immune program according to an embodiment of the present invention
  • Figure 2 is a block diagram showing a data hook of an ISG according to an embodiment of the present invention
  • Figure 3 is a block diagram showing an embodiment of an ISG according to an embodiment of the present invention Schematic diagram of ISCAD;
  • FIG. 4 is a schematic diagram showing a user interface of a CAD when a vaccine is selected according to an embodiment of the present invention
  • FIG. 5 is a schematic diagram showing a user interface when a CAD vaccine is selected according to an embodiment of the present invention
  • FIG. 6 is a schematic diagram showing a user interface when an ISCAD immune program generation module is selected according to an embodiment of the present invention
  • FIG. 7 is a schematic diagram showing a GUI of a CAD when a system of immune programs is selected according to an embodiment of the present invention
  • FIG. 8 is a schematic diagram showing an ISG distributed in a graphic format according to an embodiment of the present invention
  • FIG. 9 is a schematic diagram showing a data structure of a vaccination information processing state according to an embodiment of the present invention
  • FIG. 10 a) is a diagram showing an implementation according to the present invention
  • Figure 10 b is a block diagram showing a processing method in accordance with an embodiment of the present invention.
  • the invention will be further described in detail below with reference to the drawings and specific embodiments.
  • the embodiments of the invention are illustrative of the invention and are not intended to limit the invention.
  • Graph The concept in the graph theory and the corresponding computer algorithm.
  • a diagram is used to abstractly represent a set of objects (o ect) called vertices or nodes, some of which have links, called edges or lines (lme).
  • a sequence of nodes that are wired together between nodes is called a path.
  • a set of nodes in a graph if its edges exist only within the set of nodes, then the set of nodes and their edges form a subgraph of the graph. If all the lines in a graph are directional, the graph is a directed graph whose edges are also called arcs or arrows. The node at the end of the arrow of all the vector lines starting at a node is the subsequent node of the node.
  • Immunization schedule refers to immunization implementation rules and methods.
  • the immunization program includes the vaccination target to be vaccinated, the vaccine to be vaccinated, the number of doses, the age range of the vaccinated subjects at each dose, the interval between vaccinations, and the route of vaccination.
  • the information in the immunization program to determine which vaccine to vaccinate and which vaccine to receive, and how to inoculate the vaccine is also referred to as conditional information in this description.
  • the vaccination object completes the immunization against the disease by completing the dose number for one disease according to the immunization program.
  • Immunization program Information on the condition of a single dose of vaccination including the age at which the vaccinator is vaccinated, the optional vaccine, and the time interval between other accepted vaccinations, etc., can be expressed in a set of conditions, whether the vaccinator should be vaccinated The dose of this dose depends on whether these conditions can be met.
  • Immrniization schedule graph Refers to the immune program represented by a graph, including immune program data organized by graph structure, and corresponding computer algorithms.
  • Vaccination information processing Analytical processing and processing results based on immunization procedures, information on vaccinators.
  • the vaccinator is the recipient of the vaccine, corresponding to one of the vaccinated individuals in the immunization program.
  • the vaccinator information is information related to the vaccination of the vaccinator including information of the individual of the vaccinator, such as the age, sex of the vaccinator, and vaccination information of the vaccinator, such as the vaccination history of the vaccinator.
  • the vaccination history of the vaccinator is all vaccination received by the vaccinator, and one injection includes the vaccine vaccinated by the vaccinator and the date of vaccination.
  • the information on the one-time vaccination of the immunization program contains conditions under which the vaccinator's one injection corresponds to the vaccination, depending on the vaccinator information and whether the injection satisfies the conditions of the vaccination. If one injection corresponds to one dose of the dry immunization program, the injection is effectively vaccinated, otherwise it is ineffective.
  • Department Refers to a concept used in this description.
  • Some of the information related to the immunization program can be grouped according to the type of disease that the immunization is guarded against, called a line: the system can have the same name as its corresponding disease, such as the HepA line.
  • the immunization schedule may be independent of each other, ie, the vaccination of the vaccinated person after the injection or vaccination with the attenuated inactivated vaccine is processed. History - can be handled separately by department.
  • a line can also be obtained by combining several lines. For example, when the MMR system makes the combined vaccine MMR, the line can be treated separately as described above.
  • this age ⁇ ⁇ is defined as the cut-off age of the department.
  • Atom Vaccine A concept used in this description.
  • a meta-vaccine is a component of a vaccine product that targets a disease, such as an immunogen or immune effector for a disease.
  • a combination vaccine can be broken down into a plurality of meta-vaccinations, that is, one dose of vaccination containing the combined vaccine can be divided into vaccination of several doses of the primordial vaccine, each dose of the vaccination Vaccination with a one-way vaccine; a single injection containing a combination vaccine can be divided into several injections of a vaccine containing a dollar vaccine (cominiter): a computer in the natural sense, such as a personal computer (PC), or mobile
  • a smart phone, personal data assistant (PDA) or supercomputer usually connected by multiple functional units connected by some form of communication bus Bus, such as a processor (CPU), memory (RAM, ROM), input and output
  • CPU processor
  • RAM random access memory
  • ROM read-only memory
  • the device external storage of various storage media, wired or wireless network communication devices, and the like.
  • OS operating systems
  • application software programs running on them.
  • the application's encoding instructions are stored on a computer readable medium, and when the program is run, the program's instructions are loaded into the computer's memory and executed to provide the functionality of the method implemented by the application.
  • An application that implements a method can be either an executable program or an integrated or separate software module.
  • API application programming interface
  • Collection Data structures and algorithms involving collection sequences in the computer domain, as in the list (Ust).
  • each element in the collection is sequentially read in a loop, according to the storage location of the element, assigned to a variable, and then the content of the variable is processed; In the process, it is usually used to determine whether there is still an operation of the next element, that is, whether the end of the set sequence has been reached. The operation determines whether the traversal loop should end; if there is a next element, the next element is read for corresponding processing: if not, the loop is exited, that is, all elements of the set have been processed.
  • FIG. 1 is a block diagram showing a method for visualizing an immune program according to an embodiment of the present invention.
  • One dose of vaccination of the immunization program and its attributes, including conditional information that should be met when the dose is inoculated is represented by a node 101, 103, 105 106 in the directed graph 100; a node 101 inoculated with one dose Connected to the node 103 indicating the next dose of the inoculation with a vector line 02, the vector arrow points to the node 103 of the next dose, ie, node 101 represents the previous dose of the two doses. Sub-vaccination, node 103 indicates the next dose of vaccination.
  • Subsequent nodes 103, 105 of node 101 are the corresponding nodes for all possible next doses of a single dose of vaccination represented by node 101.
  • the vector line 104 is finally dry and the same node is used to indicate the periodic booster dose:.
  • a siart node 101 represents a first dose of vaccination of the immunization program represented by Figure 100, and an end node: 06 indicates a last dose of the immunization program.
  • An immune program map can have multiple start nodes or endpoints. The path from a start node to an endpoint indicates a possible way to complete the immunization against a disease in the immunization program represented by the immune program map. .
  • the route i0i-103-106 indicates that three doses of vaccination are required to complete the immunization required by the immunization program shown in Figure 100, the immunological program map 100.
  • An immune program map can have multiple pathways indicating possible ways to complete immunization.
  • immunological program map is to select one or several pathways in the ISG to vaccinate the vaccinated subject against various diseases as specified or recommended by the immunization program.
  • a series of ISGs may be composed of one or more immune program subgraphs associated with the vaccine of the system; in a series of ISGs, an inoculation object only needs to complete a path from a starting node to an ending point. The immunization of the line was completed.
  • the complete ISG can be of the ffl system: SG is composed of subgraphs.
  • a method of selecting a path for a line of ISGs includes determining a path representative of the history of vaccination based on a vaccination history of a vaccinator corresponding to the line, a process referred to as assessment (E va !uaiiOii). Evaluation method is For each injection in the vaccination history, in the G of the line, according to the vaccination condition information of each node,
  • a node If a node is found for an injection, this injection is effectively vaccinated. At the end of the assessment, if the immunization of the line has not been completed, the last node in the path representing the history of the inoculation can be used to determine the future inoculation required by the inoculator, any subsequent knot of the node. The point represents the next vaccination that the vaccinator can take, and the subsequent node of the node can be used to determine the future vaccination of the line that the vaccinator needs and can take. This process is called recommendation ( Recommendation).
  • Data structure 200 is a block diagram of a data structure 200 of an iSG in accordance with an embodiment of the present invention.
  • Data structure 200 is a block diagram of a data structure 200 of an iSG in accordance with an embodiment of the present invention.
  • this data structure can be used to establish an immune program map and for vaccination information processing.
  • the data structure includes the following data elements: an identifier 201 that uniquely identifies the node; a dose information information 202 corresponding to the dose of the dose corresponding to the node, including condition information 233 inoculated with the agent; The next dose of vaccination information is followed by node information 203.
  • Condition information 233 can be a set of constraints 204.
  • This dose of vaccine is vaccinated; it can be a meta-vaccine code 209, or it can be a common plague code 213.
  • Licensing allows ffi date range
  • the license's license usage date is determined by the start and end dates.
  • Minimum annual range The minimum annual range of vaccinated subjects allowed for this dose of vaccination is determined by the start and end periods, usually only the start date. Usually used only for evaluation.
  • Minimum time interval The minimum time interval between the dose of the dose and the time of the previous dose. Usually used only for evaluation.
  • Minimum time interval ⁇ The minimum interval between the dose of the dose and the time of the previous dose.
  • Recommended Age Range The recommended age range for the vaccination for this dose is determined by the start and end dates, usually using only the start date. Usually only recommended.
  • Optional vaccination 218 The vaccinated subject should receive the vaccination for the time of the previous dose if it is within a certain age.
  • the same vaccine requires vaccine 207 to be the same vaccine as the vaccine used in the previous dose.
  • This node is only used for an injection that corresponds to the evaluation of this node.
  • Tdap Tetanus-Diphtheria-Pertussis
  • Tdap Tetanus, Diphtheria anc Pertussis ⁇ Date of birth range
  • Measles, mumps and rubella MMR::: Measles, mumps and rabei! a
  • Effective Date Range 221 The effective date range for this node, determined by the start and end dates. The mark used to change the history of the immunization program, ie the conditions for a single dose of vaccination have a suitable date.
  • Age range 219 The age range of the vaccinated subjects allowed for this dose is determined by the start and end periods.
  • the vaccine 207 constraint may be the code 213 of the vaccine 210 or the element derived from the vaccine 210.
  • Vaccine 2i0 is used to store information about a vaccine; meta-vaccine 208 is used for storage
  • vaccine 210 may contain the above identification code 2] 3, and the permitted use time range 214,
  • Component list 216 is vaccine 210
  • Each component of the component list 2]6 may be the name of the component 217 and the associated system 2]2.
  • the license time range 214 is the date range for the licensed use of the vaccine 2]0. Attenuated inactivated vaccine 215
  • the meta vaccine 208 can include the identification code described above
  • vaccine code 211 is 212.
  • vaccine code 211 and line 212 are corresponding to the original vaccine.
  • the code 210 of the vaccine 210 and the component of the component 212 are identical to each other.
  • condition information 233 is described using a set of constraints 204, which is to be made in a series of ISGs.
  • the constraint 204 of any two subsequent nodes of a node does not overlap, Lang: the same constraint of the two nodes At least one of the parameters in the condition is completely exclusive. For example, the example of the value of the constraint is completely repelled:
  • the two-node vaccine constraint 207 is different: the time-related constraints of the two nodes, such as the age range 219, do not intersect. In the case where the two node constraints 204 overlap, a dose of vaccination may satisfy the constraints of the two nodes, which makes the evaluation of the vaccination history in the vaccination information processing complicated, and therefore should be avoided. This is the case.
  • the subsequent node information 203 is a list 206 of subsequent node pairs, wherein the identifier 231 of the pair 205 is an identifier of a subsequent node, and the priority 232 is all subsequent nodes of the subsequent node in the list 206.
  • the priority in the point is used to assist in determining the priority of each subsequent node selected in the vaccination information processing.
  • FIG. 3 is a block diagram diagram of the computer aided design system (ISCAD) 300 of the present invention.
  • the ISCAD 300 includes an immune program assisted design input interface 301, and an immune program storage 307. These components 301, 307 can be implemented in the form of integrated or distributed functional modules, and the SCAD 300 applications composed of these functional modules are usually stored on a computer readable medium together with an operating system and other applications.
  • the program instructions are loaded into the computer's memory and executed, so that the computer can help and guide the user to input and maintain vaccine data, graphically design, establish and maintain the immune program. Test the immunization program and related documentation.
  • the immune program assisted design input interface 30 includes an immune program object management module 302, a vaccine editing module 303, a meta vaccine editing module 304, an immune program map editing module 305, and an immune program assist design task 306.
  • the immunization program input interface 301 is also integrated with an immunization program publishing engine 308 for issuing ISGs.
  • the immune program assisted design input interface 301 can be used in conjunction with the auxiliary design task 306 for automatic generation and integrity of dependent data, maintenance, maintenance, cleanup, and the like.
  • the user can enable the immune program management module 302 and its graphical user interface to classify and manage, add, delete, copy, paste, search, select, edit, and edit objects related to the immune program, and read from the immune program storage 307 or store the immune program 307.
  • 4 is a schematic diagram of a user interface 400 when an iSCAD 300 is selected as a vaccine in accordance with an embodiment of the present invention.
  • the user interface 400 displays the browser user interface 401 of the object management module 302 and the vaccine creation user interface 402 of the vaccine editing module 303 and the output information browser 407 of the user interface 301.
  • the browser user interface 401 is used to organize and manage immune program related objects.
  • Immune program related objects can be displayed in a tree structure In the browser user interface 40, the user can search and manage the immune program related data and information according to the type of the object related to the immunization program.
  • the first level node of the tree structure may be the system 403 or the combination vaccine 404; under the system node 403 may be the classified nodes 4i0-412 belonging to the object of the system; under the combined vaccine node 404 Is a node 413-4M belonging to the classification of the object of the combined vaccine; under a classification node 410-414 may be an individual object or entity belonging to the class, the node itself may also correspond to the comprehensive object or entity of the classification, for example Immune program node 412 may correspond to a series of ISGs, and under this node 412 is an ISG 405 for the individual vaccines of the system.
  • the user can add, delete, copy, paste, search, select, edit a family 403, a combined vaccine 404, a class of object classification nodes 4i0-414,
  • an editing module corresponds to the object
  • the user can cause the editing module corresponding to ffl to edit the data of the object. Feeding, when a vaccine 406 is selected, the vaccine's data is displayed in the user interface 402 of the vaccine editing module. The user can enter or edit various attribute values of the vaccine using the user interface 402.
  • an object 405-406, 410-414 is selected, if there is a processing task corresponding to the object in the auxiliary design task module 306, the user can use the corresponding processing task to process the selected object.
  • the immune program related object data generated during the processing will be managed by the object management module 302 and will be displayed in the interface 401.
  • the user may elect to use the sputum vaccine to generate a meta-vaccine processing task, such as using the toolbar 408 of the user interface 301 to generate a meta-vaccine from the vaccine 406.
  • the method for generating a meta-vaccine from a vaccine is: Each component of a vaccine should produce a meta-vaccine, the meta-vaccine is the line of the component, and the other parameter value of the vaccine can be the corresponding parameter value of the vaccine. .
  • the output information browsing interface 407 is used for displaying, browsing, and reading the output information of each module of the ISCAD 300.
  • FIG. 5 is a schematic illustration of user interface 500 when ISCAD 300 is selected as a meta-vaccine 502 in accordance with an embodiment of the present invention.
  • the user interface 500 displays the user interface 501 of the meta vaccine editing module 304.
  • the attribute value of the selected plague 502 is displayed in the user interface 50], and the user can use the interface 501 to input, delete, modify, and edit the attribute values of the meta vaccine.
  • the assisted design task module 306 can include a vaccine immunization program generation task module that can automatically generate a vaccine or meta-vaccine ISG based on a predefined template. Skeleton, for j3 ⁇ 4 households to edit. 6 shows a schematic diagram of the user interface when the vaccine immunization program generation task 606 of the assist design task module 306 is selected [ users can select a set of vaccines 601 using the system selection user interface 600, which may be a line or combination vaccine, the group The individual dose vaccine or vaccine 602 in vaccine 601 will be displayed in vaccine dose selection user interface 603, and the user may enter the number of doses 604 of the meta-vaccine or vaccine for immunization for each meta-vaccine or vaccine 602.
  • the user can then select, for example, use button 605 to generate a framework for the ISG of each meta-vaccine or vaccine 602 for further editing.
  • the generated iSG framework of the individual vaccine or vaccine 602 may have the same number of nodes as the number of doses 604 entered, each node will have the identifier 209 or 213 of the vaccine or vaccine 602 as a vaccine constraint and Some of the constraints and values derived from the meta-vaccine or vaccine 602 or defined in a predefined template, such as the license use date 220 constraint derived from the meta-vaccine or vaccine license time range 214, and the like.
  • FIG. 7 is a schematic diagram of the UI interface 300 of the present invention when the ISG 703 of a system is selected.
  • the user interface 700 displays the ISG creation user interface 701 of the editing module 304, and the constraint selection user interface 702.
  • the selected iSG 703 will be displayed in the user interface 701.
  • Users can use the ISG Editing Toolbar 705 to add new nodes - arbitrage between nodes, such as line 706; edit line priority; copy, crop, paste, delete selected nodes including nodes, lines and ISG graphical elements and data such as constraints.
  • the user can select the line 706 and then use the drop down list in the edit toolbar 705 to select the desired priority to assign to the line 706.
  • Different priority values can be used with different line styles. (line style) indicates.
  • the user wants to add a constraint to a node 710, such as an age range constraint, the user may choose to select the constraint in the constraint list 702 and drag and drop it to the node 710, the constraint Will be added to this node 710.
  • the household can also choose to copy a constraint 709 from one node and then paste it into another node 710.
  • the user can edit the interface 708 using constraints, such as by using the mouse to double-click the node 707 to activate the constraint editing interface 708, editing the values of the various attribute variables of the constraint.
  • constraints such as by using the mouse to double-click the node 707 to activate the constraint editing interface 708, editing the values of the various attribute variables of the constraint.
  • the auxiliary design task module 306 can include a subsequent node vaccine usage analysis task module.
  • the user can select the task on the user interface 301, for example using the toolbar 7]2.
  • the module is a node selected in the user interface 70.
  • the output information browser 407 lists information about the same type of meta-vaccine that appears in the subsequent nodes of the node and has not yet appeared, such as a meta vaccine. The identifier and its name, the user can check and consider the possibility of a non-existing meta-vaccine as a vaccine 207 for the subsequent node of the node.
  • the auxiliary design task module 306 can include a subsequent node overlap analysis task module.
  • the user can select the task module as a node selected in the user interface 701 on the user interface 301, for example, using the toolbar 713, and list whether the subsequent nodes of the node exist in the output information browser 407.
  • the user can check the information of the constraint overlap nodes listed in the output information browser 407 and consider the possibility of establishing an immune procedure in the event that the node constraints 204 overlap in subsequent nodes.
  • the auxiliary design task module 306 can include associated data maintenance, inspection, and cleanup task modules.
  • the user can select the task module on the user interface 30, for example, using the toolbar 714 to verify the immunization program including the vaccine, the meta vaccine, the data format of the SG, the inter-data dependencies, the valid range of the data values, and the like.
  • the related data maintenance, inspection, and cleaning task modules of the auxiliary design task module 306 can also automatically complete the maintenance of the immune program in cooperation with other modules.
  • the associated data maintenance, inspection, and cleanup task module of the auxiliary design task module 306 can look up objects that depend on the vaccine, such as a meta-vaccine that relies on the vaccine, and Depending on the SG node, if an object dependent on the vaccine is found, a prompt warning message indicating the data dependency is displayed in the user interface 301, for example, in a pop-up session window manner, the user is requested to confirm the deletion operation. It should contain subjects who depend on the vaccine.
  • the immune program management module 302 can include a dynamic recipe, toolbar generation and management system based on the immune program related objects, which can be generated and managed based on the selected objects 403-406, 410-414 of the user. Some task menus and toolbars of the selected objects guide the user through some related tasks.
  • the immunization program publishing engine 308 is used for the publication of immunization programs in various formats.
  • the immunization program publication engine 308 can be integrated into the immunization program user interface 30.
  • the user can select, on the user interface 301, for example, using the toolbar 715, the publishing engine 308 to issue, convert, and output the immunization program in a format selected by the user.
  • the publishing engine 308 will read the data from the immune program storage 307, convert it to the selected format, and output the immune program, for example, as described later in conjunction with FIG.
  • the format of the publication of the immunization program for the average reader user; and the publication of the immunization program in XML document format for transmission to the vaccination information processing service system and used by the system [: users can choose single or several vaccines or meta-vaccines, single line or Several departments of ISG published. The user can change the default format of the immune program release, such as using the default format of the system's menu settings in the input interface 301.
  • FIG 8 is a schematic diagram of an ISG 800 issued in a graphical format in accordance with the present invention.
  • the ISG 800 can have multiple immune block diagrams 801 and a legend 803.
  • Each block diagram 801 can have one or more node tables 804; a node of the SG, fed as node 707, can correspond to a node table in block 801, such as node table 804; Show some or all of the constraints of the node it corresponds to.
  • Each block diagram 80 may have one or more annotations 802 for listing some of the information of the block diagram, such as information about the vaccine used in the block diagram, and the shared information between the node tables in the block diagram.
  • Figure 803 is used to illustrate the meaning of each character, symbol and graphic element in the frame 801.
  • FIG 9 is a data structure of a process state 1100 of a storage process for use in inoculation information processing in accordance with the present invention.
  • Process state 1100 can include a general state 1120 and states 1123 of the various systems; a recommended date range 1121 in the general state 1120. [ ⁇ 3 ⁇ 43 ⁇ ⁇ 1 ] is used to set the future vaccination recommendation date range of interest to the user, where T sian is the start date and T end is the due date; states 1124- 126 and 1128 - 1129 in process state 1100 may be The implementation of the list, the state L127 can be a Boolean variable, when it is TRUE, it indicates that the inoculation of the system has been completed, and when it is FALSE, it indicates that it has not been completed.
  • Figure 10 a is a block diagram showing a method for performing inoculation information processing using an ISG in the embodiment of the present invention.
  • the vaccinator information is received and the vaccinator information is processed.
  • step 201 the process state 1100 is initialized, including initialization states ⁇ 24- ⁇ 28, such as clearing states 1124-1126 and 1128 storage units, etc., and setting the system end identifier 1127 to FALSE, and the like.
  • step 1202 some of the pre-treatment tasks need to be performed so that the vaccination history of the vaccinator and the future vaccination required thereof can be processed step by step.
  • Each of the meta-vaccines contained in the vaccine is then injected and stored in the vaccination history i i24 of the corresponding line by the meta-vaccine and the inter-injection primordial injection, and can be sorted according to the injection time 1124 in the injection time;
  • 2 Check the time interval between the injections of the vaccination containing the attenuated inactivated vaccine Whether it meets the immunization program, non-conforming injections are invalid vaccinations. Injections and invalidation determined to be ineffective vaccination in the pretreatment are recorded in the evaluated injection list 1129.
  • the vaccination history in the vaccinator information and the vaccinations required in the future are processed on a case-by-case basis.
  • the treatment of a line should first assess the vaccination history of the line of the vaccinator 1124, and then determine the future vaccination of the line required by the vaccinator within the recommended date range 1121 and store the recommended vaccination 1126 in the line.
  • each department can have different processing methods. The method of processing a series will be described later in conjunction with Figure 10 b).
  • step 1204 some post-processing tasks need to be performed.
  • the following tasks are usually required: 1) Check the recommended interval between the recommended vaccinations for each of the attenuated inactivated vaccines included in the recommended vaccination 1126 and the vaccination history of the vaccinated person with attenuated inactivated vaccine Whether the time interval between injections meets the requirements of the immunization program; the recommended vaccination in which the time interval is not met will be adjusted, usually after the vaccination time of the recommended vaccination, until the delay between the vaccination and other detoxification
  • the time interval between the recommended vaccination of the live vaccine and the vaccination history of the vaccinator includes the time interval for the injection of the attenuated inactivated vaccine. The immunization schedule is not met.
  • the recommended vaccination is recorded; 2) Converting the vaccination in the recommended vaccination to vaccination, the conversion method is if a meta-vaccine corresponding to all components in the component list 216 of a vaccine 210 appears in the recommended vaccination, ⁇ If the vaccination time in the recommended vaccination of these meta-vaccinations is non-empty, use the vaccine and the time to produce a vaccine recommendation. Vaccination; Meta-vaccination that cannot be converted during the recommended vaccination should be recorded; 3) Generate a treatment report according to the treatment status 1100, for example, generate a vaccination history evaluation report according to the state 1128-1129 and determine whether to generate a recommendation report according to the status 127, such as generating a recommendation report. Generating a future vaccination recommendation report based on state 1126;
  • processing ends and processing report 1103 is returned.
  • FIG. 10 b) is a block diagram showing a flow of a processing method for a system according to an embodiment of the present invention.
  • the processing of a series begins at step 1211.
  • step 1212 all possible subsequent node sets 1125 are assigned as a set of all the starting nodes of the system.
  • steps 1213-1214 if there is an unevaluated injection in the vaccination history 1124, the vaccination history is evaluated.
  • the method of estimating the history of vaccination is to determine the vaccination history according to the vaccination time.
  • Each injection in 124 that does not appear in the evaluated injection list 1129 determines a node in the ISG of the system; Injecting to find a node, this injection should be an invalid vaccination.
  • the injection and evaluation results can be recorded in the department's evaluated injection list 1128 for generation Process the report.
  • steps 1215-1216 if the vaccination of the line has not been completed, the subsequent node required for the last node in the path determined by assessing the vaccination history 1124 of the line at step 1214 is used to derive the desired amount for the vaccinator. Future vaccination.
  • step 1217 the processing of the system ends and returns to the main flow control 1203.
  • a method for estimating the inoculation history of a vaccinator, 1124, which can be used in step 1214 to assess a vaccination history of a line the method having the following steps;
  • the unevaluated injection is taken in the vaccination history 1124 according to the vaccination time sequence; otherwise, the evaluation ends and the system is withdrawn; b) verifying that the injection satisfies all of the constraints of one of the subsequent node sets 1125; if so, the injection is a valid vaccination, adding the injection to the evaluated injection list 1128, continuing with c); Recording the injection as an invalid vaccination and adding the injection and the cause of the invalidation in the evaluated injection list 1128, transferring to execution a;
  • step b) if there is priority information in the subsequent node information, when checking whether an injection satisfies all the constraints of one of the subsequent node sets 1125, the priority should be high.
  • the low priority takes each node to check whether the injection satisfies all the constraints of the node taken. If there is no priority information in the subsequent node information, each node can be taken in any order to check whether the injection satisfies all the constraints of the node taken.
  • Embodiments of the present invention provide a method for a vaccinator to recommend a future vaccination required within the recommended date of the model, which may be used in step 1216 to recommend a future vaccination of a line, if a future vaccination of the line is recommended There is no need to go to the termination point of the ISG of the system or to use the termination point of the ISG of the system but there is no optional vaccination constraint 218.
  • the method has the following steps - a) if in the subsequent node set 1125 If there is a node that has not been used for recommendation, then in the set 1125, ⁇ is used for the recommended node; otherwise, the recommended processing is ended;
  • the method of checking the constraint condition related to the time range may be determining [ ⁇ , ⁇ and the intersection of the time-range constraint conditions of the node [, 3 ⁇ 4, and judging Whether the intersection is empty.
  • the constraints related to the time range are mainly: License validity period range 220, effective date range 221, age range 219, birth period 0 range, and recommended age range, recommended time interval, minimum time interval I, etc. Condition; if the time intersection [ ⁇ ⁇ ] is not empty, the constraint related to the time norm is satisfied, otherwise it is not satisfied. If the above time intersection [T rf , T n ] has been determined in step b), then this value can be used in step c).
  • a recommendation is made for the vaccinator on the recommended date.
  • One method of future vaccination required is to first use the vaccinator information to check if the optional vaccination 218 constraint for the endpoint is met; if satisfied, the endpoint is processed without the optional vaccination 218 constraint, continue to This endpoint is used for the recommendation of the department; if not, the end identifier 1127 of the system is set to indicate that the immunization of the system has been completed, and the recommendation process is terminated.
  • the recommended future vaccination depends on the recommended phase 0 range 1121 and can be used as a recommended node, so the recommended future vaccination may include multiple vaccines and different vaccination periods. To narrow down the specification, some other conditions can be used, such as using priority to determine the trade-off or prioritization of each node when it is used for recommendation, and defining a narrower recommended date range 1121, and so on.
  • Another embodiment of the present invention provides a method for optimizing the cut-off age ⁇ ⁇ of a series as follows - after the steps in the processing method described in FIG. 0b), after the step 211 and before the step 1212, the inoculator is first tested. Whether the age has exceeded the cut-off age ⁇ ⁇ ; if the vaccination does not need the vaccination, the vaccination can withdraw from the department; otherwise, the system still needs to be treated, and the feeding step is as follows.
  • This method is suitable for only need
  • the advantage is that they can save processing time and make it clear that the vaccinator does not need the vaccination.
  • the disadvantage is that this method does not give an assessment of the system. For customers who need to evaluate the vaccination history, the following methods can be used.
  • Another embodiment of the present invention provides a method for optimizing the processing of a series of cutoff ages ⁇ ⁇ .
  • it is first checked whether the age of the vaccinator has exceeded the cut-off age A T , and if the vaccinator does not need the vaccination, the vaccination may withdraw from the treatment; otherwise, Recommended processing, for example, continue with the steps 216.
  • the above methods can be implemented in a computer software program and combined into a module or architecture application program interface (API) for convenient use.
  • the method or function for processing the vaccination information may include an application interface function Report process (ClientInformation client), which accepts the vaccinator information Clientlnformation, processes and returns the processed report Report.
  • ClientInformation client an application interface function Report process
  • the computer software program implementing the above method is deployed on a computer readable medium, such as a hard disk, and the functions of the method of processing the vaccination information described above can be provided when the instructions of the program are loaded into the memory of the computer and executed.
  • One implementation of the present invention is a method of updating an SG, using: SCAD to update the SG, issuing the ISG, to an application system that processes the vaccination information using the ISG, the method comprising the steps of:

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed are an immunization procedure graph and a building method therefor and an inoculation information processing method and system. In the present invention, a visual immunization procedure of a digraph is used, one-dose inoculation is indicated by one knot in the digraph, and the knot is connected with another knot of the next-dose inoculation through a vector line in the diagraph. The inoculation information processing method comprises: searching for one or more paths standing for inoculation records of inoculators in the immunization program diagraph and recommending future inoculation to the inoculators according to the paths. By the application of the present invention, time for reflecting modifications of the immunization program to the inoculation information processing system is shortened, and high availability of the inoculation information processing system is improved.

Description

说 明 书 免疫程序图及建立方法、 处理接种信息的方法和系统 技术领域  Description of the book Immunization program map and method of establishment, method and system for processing vaccination information
本发明属于计算机软件领域,特别涉及一种免疫程序图及建立方法、处理接 种信息的方法和系统。 背景技术  The invention belongs to the field of computer software, and in particular relates to an immune program diagram and a method for establishing the same, and a method and system for processing the seeding information. Background technique
疫苗是一种生物制品, ¾于激发动物体对疾病的免疫力, 从而防止或减轻疾 病病原感染的影响。疫苗产品的说明给出了基于临床分析研究而制定的疫苗的使 用方法,通常通过多剂次接种才能达到最好的预防效果。在免疫接种实施过程中 还存在着一些情况在疫苗产品的说明书中并不会涉及, 但也须正确处理。 比如, 不同疫苗的同时及异时接种问题;有多个或多次减毒灭活疫苗接种时接种时间的 选择等。通常国家疾病防制中心负责制定免疫接种相关的规则,规则中除了疫苗 产品的使用规定, 也给出了在免疫接种实际实施过程中的一些情况的处理方法。 免疫程序即为基于这一规则的免疫接种实施方法。  A vaccine is a biological product that stimulates the body's immunity to disease, thereby preventing or reducing the effects of disease pathogen infection. The description of the vaccine product gives a method for the use of a vaccine based on clinical analysis studies, usually through multiple doses of vaccination to achieve the best preventive effect. There are still some situations in the implementation of immunization that are not covered in the instructions for the vaccine product, but they must be handled correctly. For example, simultaneous and isochronous vaccination of different vaccines; selection of vaccination time for multiple or multiple attenuated inactivated vaccinations. Usually, the National Center for Disease Control and Prevention is responsible for formulating rules related to immunization. In addition to the regulations on the use of vaccine products, the rules also provide some treatments for the actual implementation of immunization. The immunization program is an immunization implementation method based on this rule.
在免疫接种实践中,需要计算机程序来解释免疫程序并自动分析处理与免疫 接种相关的数据,比如评估一个人的免疫接种史及推荐未来这一人所需的免疫接 种。这一计算机程序还应包含免疫接种实施者的一些决策功能, 比如与免疫程序 直接相关的有; 更新及使用最新版本的免疫程序; 当处理历史数据时选择合适版 本的免疫程序。  In immunization practice, a computer program is needed to interpret the immunization program and automatically analyze and process data related to immunization, such as assessing a person's immunization history and recommending the immunizations required for this person in the future. This computer program should also include some of the decision-making functions of the immunization practitioner, such as those directly related to the immunization program; updating and using the latest version of the immunization program; and selecting the appropriate version of the immunization program when processing historical data.
新疫苗的引入、 i日疫苗的退出以及疫苗使用方法的改变使得免疫程序经常改 变且越来越复杂;而免疫程序的改变应该尽快地反映在处理接种信息的计算机程 序中, 以便提高处理接种信息系统的高可用性(iugh av labiUty 这就需要一个 工具以便有效地设计、维护和管理免疫程序, 特别是用于接种信息处理的计算 程序的免疫程序。这一工具的设 if应考虑到接种信息处理的计算机算法及程序软 件的设计, 反之亦然。 除了正确解释免疫程序, 处理接种信息的计算机程序作为 应 ^软件或应用软件的一部分亦应考虑软件的可维护性,这包括与免疫程序的改 变相关的可维护性。 发明内容 The introduction of new vaccines, the withdrawal of i-day vaccines, and changes in vaccine use methods have made immunization procedures constantly changing and more complex; changes in immunization procedures should be reflected in computer programs that process vaccination information as soon as possible in order to improve treatment of vaccination information. High availability of the system (iugh av labiUty) This requires a tool to effectively design, maintain and manage the immunization program, especially the immunization program used to calculate the information processing program. The design of this tool should take into account the vaccination information processing. Computer algorithm and program software design, and vice versa. In addition to correctly interpreting the immunization program, the computer program that processes the vaccination information should also consider the maintainability of the software as part of the software or application software, including changes to the immunization program. Relevant maintainability. Summary of the invention
本发明的一个目的是要提供一个高可用性处理免疫接种的接种信息的方法 和系统;本发明的另一个目的是提供一个能减少免疫程序的改变反映到免疫接种 信息处理系统中的时间的免疫程序建立及维护方法和系统,以便提高处理接种信 息系统的高可用性;本发明的另一个目的是提供一个即可以用于免疫程序可视化 建立及维护方法和系统也可以用于处理接种信息的方法和系统的免疫程序图。  It is an object of the present invention to provide a method and system for high availability processing of vaccination information for immunization; it is another object of the present invention to provide an immunization program that reduces the time required for changes in the immunization program to be reflected in the immunization information processing system. Establishing and maintaining methods and systems to improve the high availability of processing vaccination information systems; another object of the present invention is to provide a method and system that can be used for immunological program visualization establishment and maintenance methods and systems, as well as for processing vaccination information Immune program map.
发明的技术解决方案如下- 一种免疫程序图,其特征在于, 包括多个结点和多条矢线,  The technical solution of the invention is as follows - an immunological program diagram comprising a plurality of nodes and a plurality of vector lines,
a) 一个所述结点表示免疫程序的一剂次接种及其属性, 所述属性包括接种 该剂次接种的条件信息;  a) one of said nodes represents a dose of vaccination of the immunization program and its attributes, said attributes including conditional information for vaccination of the dose;
b) 一条所述矢线连接所述接种的结点和所述接种的一个下一剂次接种的 结点, 矢线指向所述的下一剂次接种的结点。  b) A vector line connecting the inoculated node and the next inoculated node of the inoculation, the vector line pointing to the node of the next dose inoculation.
采用以下数据结构存储免疫程序图的一个结点及其后续结点的信息并能够 用干接种信息处理:  The following data structure is used to store information about a node of the immune program map and its subsequent nodes and can be processed with dry vaccination information:
所述数据结构包括以下数据元素:(1 )唯一地识别所述结点的识别符(201 )、 ( 2) 所述结点所对应的一剂次接种的剂信息 ( 202) 以及 ( 3) 所述接种的下-一 剂次接种信息后续结点信息 (203)。  The data structure includes the following data elements: (1) an identifier (201) that uniquely identifies the node, (2) a dose of agent information (202) corresponding to the node, and (3) The next inoculation of the inoculation is followed by information on the subsequent node information (203).
所述剂信息包括一组约束条件。  The agent information includes a set of constraints.
所述约束条件中的疫苗约束条件是元疫苗的信息。  The vaccine constraint in the constraint is information on the meta-vaccine.
所述约束条件中包括有一个结点的有效日期范围 (221 ) 的约束条件。 所述后续结点信息 (203) 包括每个后续结点的优先级信息。  The constraint includes a constraint of a valid date range (221) of a node. The subsequent node information (203) includes priority information for each subsequent node.
一种生成及维护以免疫程序图组织的、 供接种信息处理使用的免疫程序的 方法,在计算机上提供图形用户界面,使用户能够建立及维护前述的免疫程序图, 包括;  A method of generating and maintaining an immune program for use in vaccination information processing organized by an immunological program, providing a graphical user interface on a computer to enable a user to establish and maintain the aforementioned immune program map, including;
以图形方式建立、 编辑所述免疫程序图的结点及矢线;  Graphically establishing and editing the nodes and the vector lines of the immune program map;
输入、 编辑所述免疫程序图中的结点的属性数据 (200)。 所述用户界面包括一个基于免疫程序相关对象的动态菜单和工具条生成和 管理模块,用于生成和管理基于被选中的免疫程序相关对象的任务菜单、工具条, 以引导 ]¾户建立、 维护及管理免疫程序图。 Enter and edit the attribute data (200) of the node in the immune program map. The user interface includes a dynamic menu and toolbar generation and management module based on an immune program related object for generating and managing a task menu and a toolbar based on the selected immune program related object. To guide, build, maintain, and manage immune program maps.
所述用户界面还包括免疫程序辅助设计任务模块, 用于免疫程序图中相互 关联的数据的自动生成及完整、 自洽性的检验及维护。  The user interface also includes an immune program assisted design task module for automatically generating and completing, self-consistent inspection and maintenance of interrelated data in the immune program map.
所述免疫程序辅助设计任务模块包括由疫苗生成元疫苗的任务。  The immune program assisted design task module includes the task of generating a meta-vaccine by a vaccine.
所述免疫程序辅助设计任务模块包括由疫苗或元疫苗生成疫苗或元疫苗的 免疫程序图框架的任务。  The immune program assisted design task module includes the task of generating a vaccine or meta-vaccine immune program map framework from a vaccine or meta-vaccine.
所述免疫程序辅助设计任务模块包括分析一个结点的后续结点间的约束条 件重叠的任务;  The immune program assisted design task module includes a task of analyzing constraint overlap between subsequent nodes of a node;
判断两结点约束条件没有重叠的判据是:比较两结点的相同的约束条件的参 数值范围, 如果存在两结点任一相同约束条件的参数值是完全相斥的, 则该两结 点没有重叠。  The criterion for judging that the two node constraints do not overlap is: comparing the range of parameter values of the same constraint of the two nodes. If there are two nodes with the same constraint, the parameter values are completely repulsive, then the two knots The points do not overlap.
所述的生成及维护以免疫程序图组织的、 供接种信息处理使 ¾的免疫程序 的方法还包括在该计算机上, 发行建立及维护的免疫程序图。  The method of generating and maintaining an immune program organized by the immune program map for processing the vaccination information further includes issuing an immune program map on the computer for establishing and maintaining.
所述的发行建立及维护的的免疫程序图是指以图形格式发行免疫程序图, 包括:  The immune program map established and maintained by the distribution refers to the release of the immune program map in a graphic format, including:
a) 多个免疫程序框图, 所述免疫程序框图中的一个结点表对应于所述建立 的免疫程序图的一个结点, 所述结点表用于显示所述结点的约束条件; 及  a) a plurality of immune program block diagrams, a node table in the immune program block diagram corresponding to a node of the established immune program map, the node table being used to display constraints of the node;
b) 一个图例用于说明所述免疫程序框图中各符号、 字符、 字符串、 图形元 素的含义。  b) A legend is used to illustrate the meaning of symbols, characters, strings, and graphic elements in the immune block diagram.
一种处理接种信息的方法, 所述方法中使 ^到的免疫程序基于前述的免疫 程序图, 所述免疫程序图的关于疫苗的信息是 元疫苗信息,所述方法包括以下 步骤: A method of processing vaccination information, wherein the immunization program is based on the aforementioned immunological program map, and the information about the vaccine of the immunization schedule is meta-vaccine information, the method comprising the steps of:
a) 初始化过程状态 ( 1100);  a) initialization process status (1100);
b) 预处理, 包括  b) pre-processing, including
将接种者的接种史中的各次注射转换成元疫苗注射、 并存储于系接种史 ( 1124) 中;  Each injection in the vaccination history of the vaccinator is converted into a vaccination injection and stored in the vaccination history (1124);
检验含减毒灭活疫苗的元疫苗注射间的时间间隔是否符合免疫程序规定, 不符合的元疫苗注射是无效接种并被记录; To check whether the time interval between the injections of the vaccination containing the attenuated inactivated vaccine complies with the immunization procedures. Non-conforming vaccinations are ineffective and vaccinated;
C) 逐系评估推荐处理;  C) reviewing the recommendation process on a case-by-case basis;
d) 后处理, 包括  d) post-processing, including
检查推荐接种 (U26 ) 中各含减毒灭活疫苗的接种间的时间间隔及与接种 史中各含减毒灭活疫苗的注射间的时间间隔是否符合免疫程序的规定;其中时间 间隔不符合的推荐接种将被调整,使其接种 间与其它含减毒灭活疫苗的锥荐接 种或注射的时间间隔符合免疫程序的规定;  Check whether the time interval between the inoculations containing the attenuated inactivated vaccine in the recommended vaccination (U26) and the time interval between the injections containing the attenuated inactivated vaccine in the vaccination history are in accordance with the immunization procedures; The recommended vaccination will be adjusted so that the time interval between the vaccination and other conical vaccinations or injections containing the attenuated inactivated vaccine is in accordance with the immunization schedule;
转换推荐的未来接种中的元疫苗接种到疫苗接种;  Convert the recommended vaccination in the future vaccination to the vaccination;
生成处理报告。  Generate a processing report.
逐系评估推荐处理的步骤中对一系的处理方法为- a) 初始化后续结点集合 (1125 ) , 将所述系的所有始结点的集合赋给所述 后续结点集合;  The processing method for the system in the step of evaluating the recommendation process is - a) initializing the subsequent node set (1125), assigning the set of all the initial nodes of the system to the subsequent node set;
b) 如接种者有所述系的接种史, 则评估所述系接种史- b) If the vaccinator has a history of vaccination of the line, the vaccination history of the phylogenetic system is assessed -
0 如接种者的所述系的免疫接种尚未完成, 则推荐所述系未来接种。 评估所述系接种史的一个方法为: 0 If the immunization of the line of the vaccinator has not been completed, the future vaccination is recommended. One way to assess the history of vaccination is to:
a) 如果所述系接种史中尚有未评估的注射, 则在所述接种史中依注射时间 先后取下 ·未 ^估注射; 否则所述系评估结束, 退出所述系评估处理;  a) if there is still an unevaluated injection in the vaccination history, the injection is taken in the vaccination history according to the injection time; otherwise the evaluation is over, and the evaluation process is withdrawn;
b ) 检验接种者个人信息及所述未评估接种是否满足后续结点集合 (1 125 ) 中的某一个结点的所有约束条件; 如果满足, 则所述注射为有效接种, 执行 c ); 否则转去执行 a);  b) checking the vaccinator's personal information and whether the unevaluated vaccination satisfies all constraints of one of the subsequent node sets (1 125 ); if satisfied, the injection is a valid vaccination, c); otherwise Go to execution a);
c )检查所述有效接种所对应的结点是否是一个终结点; 如不是终结点, 则 取所述结点的所有后续结点并赋给后续结点集合 (1125), 转去执行 a); 否则置 位所述系的结束标识符为已完成, 退出所述系评估。  c) checking whether the node corresponding to the valid vaccination is an end point; if not the end point, taking all subsequent nodes of the node and assigning it to the subsequent node set (1125), and then performing a) Otherwise, the end identifier of the system is set to complete, exiting the system evaluation.
所述推荐一系未来接种是指确定在推荐日期范围 [Tstaii, U内一系的未来 接种、且推荐该系的未来接种不用到该系的免疫程序图的终结点或虽用到该系的 免疫程序图的终结点但该终结点没有可选接种 (218) 约束条件, 所述方法包括 以下步骤: The recommendation of a series of future vaccination refers to determining the future vaccination of a line within the recommended date range [T staii , U, and recommending that the future vaccination of the line does not require the end of the system's immune program map or although the system is used The endpoint of the immune program map, but the endpoint has no optional vaccination (218) constraints, and the method includes the following steps:
a) 如果在后续结点集合 (1125 ) 中尚有未曾用于推荐的结点, 则在所述集 合中取下一未曾 ]¾于推荐的结点; 否则结束本系推荐处理; a) if there are still nodes in the subsequent node set (1125) that have not been used for recommendation, then in the set Take the next one in the middle] 3⁄4 in the recommended node; otherwise, end the recommended processing;
b) 使用所述推荐日期范围 [T5t Ί;„]及接种者个人信息检验所述结点的约 束条件 (204) 中的各约束条件是否满足; 如不满足, 则转去 ah b) using the recommended date range [T 5t Ί; „] and the vaccinator's personal information to check whether the constraints in the constraint (204) of the node are satisfied; if not, then go to ah
c) 确定 [T t, TS,J及所述结点的与时间范围有关的约束条件的交集 c) determine the intersection of [T t , T S , J and the constraints of the time range related to the node
[Trf, Trt] , 生成一个未来接种包含所述结点的疫苗约束条件所确定的元疫苗及所 述交集 [Trf,Tj, 记录所述未来接种; 转去 a)。 [T rf , T rt ], generating a meta-vaccine determined by future vaccination containing the vaccine constraints of the node and the intersection [T rf , Tj, recording the future vaccination; transferring a).
19. 根据权利要求 16所述的处理接种信息的方法, 其特征在于, 所述推荐 一系未来接种是指确定在推荐日期范 I [TstartJ Te;id] ή·一系的未来接种,推荐该系 的未来接种时要 ]¾到该系的免疫接种图的终结点,该终结点包含有可选接种约束 条件时, 步骤为- 首先检验所述可选接种约束条件是否满足; 如满足, 则按无可选接种约束 条件的终结点继续推荐处理; 否则所述系的免疫接种已完成, 结束所述系推荐处 所述逐系评估锥荐处理中对一系的处理的一个方法为: 如果所述系有系的 截止年龄, 劑在评估处理前先检验接种者年龄是否已超过所述截止年龄,超过则 退出所述系的处理; 否则继续所述系的评估和推荐处理。 19. The method of processing vaccination information according to claim 16, wherein the recommending a future vaccination refers to determining a future vaccination on a recommended date, I [T startJ T e; id ] 一· It is recommended that the future inoculation of the line be 3⁄4 to the end of the line's immunization map, which includes the optional inoculation constraint, the step is - first check if the optional inoculation constraint is met; , then continue the recommendation process according to the endpoint without the optional vaccination constraint; otherwise, the vaccination of the system has been completed, and one method of processing the system in the system-by-system evaluation process is : If the line has a cut-off age, the agent checks whether the age of the vaccinator has exceeded the cut-off age before the evaluation process, and exits the treatment of the line if it exceeds; otherwise, the evaluation and recommended treatment of the line are continued.
所述逐系评估推荐处理中对一系的处理的一个方法为: 如果所述系有系的 截止年齢, 且在评估结束后, 所述系接种程序尚未完成, 则在推荐处理前, 先检 验接种者年龄是否已超过所述截止年龄,超过则退出所述系的处理; 否则继续所 述系的推荐处理。  One method for the one-line evaluation of the treatment in the recommendation process is: if the system has a deadline for the system, and after the evaluation is completed, the vaccination procedure is not completed, then the test is performed before the recommendation process Whether the age of the vaccinator has exceeded the cut-off age, and if it exceeds, the treatment of the system is withdrawn; otherwise, the recommended treatment of the system is continued.
一种系统, 包括: 用于执行前述方法的各步骤的装置。 前述方法为: α ) -种生成及维护以免疫程序图组织的、 供接种信息处理使用的免疫程序的方法, 以及 (2) —种处理接种信息的方法。 有益效果:  A system comprising: means for performing the steps of the foregoing method. The foregoing methods are: α) - a method of generating and maintaining an immune program organized by an immunological program for use in vaccination information processing, and (2) a method of processing vaccination information. Beneficial effects:
一方面, 本发明提供了一个建立及维护 ISG的方法和系统, 用户可以在计算 机上以图形方式直观地设计、编辑、浏览 ISG各剂次接种对应的各结点间的关系, 以及输入、 编辑、 管理 ISG的数据。 系的引入也简化了含联合疫苗的各剂次接种 间的依赖关系, 便于 ISG的设计、 维护及使]¾。 另一方面, 本发明提供了 ·个使用 BG处理接种信息的方法和系统。 因为上 面所述的方法减少了免疫程序改变反应到处理接种信息的系统中的时间,所以这 一系统的高可用性性能得以提高。系的引入也使得实现处理接种者信息方法的软件 更容易设计与维护, 进而使得这一处理接种者信息的系统更容易维护。 用户可以 使 ffl这一使 ffl ISG表示免疫程序的系统处理接种者信息。 In one aspect, the present invention provides a method and system for establishing and maintaining an ISG. The user can graphically and intuitively design, edit, and view the relationship between the nodes corresponding to the ISG doses on the computer, and input and edit. Manage ISG data. The introduction of the system also simplifies the dependence of each dose of the combination vaccine, facilitating the design, maintenance and operation of the ISG. In another aspect, the present invention provides a method and system for processing vaccination information using BG. The high availability performance of this system is improved because the method described above reduces the time required for the immune program to change the response to the system in which the vaccination information is processed. The introduction of the system also makes it easier to design and maintain software that processes the vaccinator information method, thereby making the system for processing vaccinator information easier to maintain. The user can process the vaccinator information by ffl, a system that causes the ffl ISG to represent the immunization program.
本发明将免疫程序中涉及到的纷纭复杂的各种与接种疫苗有关的数据有机 地集成起来, 为医疗机构或个人用户提供了一个便于使用的数据平台和系统, 该 数据平台和系统能为用户提供快速、 高效、 准确地接种疫苗相关服务, 主要包括 疫苗接种的评估和推荐。 對图说明  The present invention organically integrates various vaccination-related data involved in the immunization program to provide an easy-to-use data platform and system for medical institutions or individual users. The data platform and system can be used for users. Provide rapid, efficient and accurate vaccination related services, including evaluation and recommendation of vaccination. Description of the figure
图〗 为表示依据本发明一实施例的免疫程序可视化方法的框图示意图; 图 2 为表示依据本发明一实施例的 ISG的数据结钩的框图示意图- 图 3 为表示依据本发明一实施例的 ISCAD的框图示意图;  Figure 2 is a block diagram showing a method for visualizing an immune program according to an embodiment of the present invention; Figure 2 is a block diagram showing a data hook of an ISG according to an embodiment of the present invention - Figure 3 is a block diagram showing an embodiment of an ISG according to an embodiment of the present invention Schematic diagram of ISCAD;
图 4 为表示依据本发明一实施例的 CAD当一个疫苗被选中^的用户界 面示意图;  4 is a schematic diagram showing a user interface of a CAD when a vaccine is selected according to an embodiment of the present invention;
图 5 为表示依据本发明一实施例的 CAD当一个元疫苗被选中时的用户 界面示意图;  5 is a schematic diagram showing a user interface when a CAD vaccine is selected according to an embodiment of the present invention;
图 6 为表示依据本发明一实施例的 ISCAD免疫程序生成模块被选中时的 用户界面示意图;  6 is a schematic diagram showing a user interface when an ISCAD immune program generation module is selected according to an embodiment of the present invention;
图 7 为表示依据本发明 实施例的 CAD当一系免疫程序被选中时的 ]¾ 户界面示意图;  7 is a schematic diagram showing a GUI of a CAD when a system of immune programs is selected according to an embodiment of the present invention;
图 8 为表示依据本发明 实施例的以图形格式发行的 ISG的示意图; 图 9 为表示依据本发明一实施例的接种信息处理状态的数据结构示意图- 图 10 a) 为表示依据本发明一实施例的接种信息处理服务请求的处理方法 的框图示意图;  8 is a schematic diagram showing an ISG distributed in a graphic format according to an embodiment of the present invention; FIG. 9 is a schematic diagram showing a data structure of a vaccination information processing state according to an embodiment of the present invention - FIG. 10 a) is a diagram showing an implementation according to the present invention A block diagram of a method of processing a vaccination information processing service request;
图 10 b) 为表示依据本发明一实施例的一系的处理方法的框图示意图。 以下将结合附图和具体实施例对本发明做进一步详细说明。本发明的实施例 是用倒子来说明本发明, 而不是限制本发明。 Figure 10 b) is a block diagram showing a processing method in accordance with an embodiment of the present invention. The invention will be further described in detail below with reference to the drawings and specific embodiments. The embodiments of the invention are illustrative of the invention and are not intended to limit the invention.
一些用于说明本发明的实施例的特征的词汇定义如下。  Some terms used to describe the features of embodiments of the present invention are defined below.
图 (graph): 指数学图论 (graph theory) 中的概念及相应的计算机算法。 图 用于抽象表示一组被称为顶点 (vertices)或结点 (node) 的对象(o ect), 其中 有些对象间有关联(link), 称为边 (edge)或线 (lme)。 一个结点间有线相连的 结点序列称为路径(path)。 一个图中的一组结点如果其边仅在该组结点内存在, 则这组结点及其边构成该图的一个子图。如果一个图中所有的线是有方向的, 则 该图是有向图 (directed graph), 其边也被称为弧 (arc) 或矢线 ( arrow)。 始于 一个结点的所有矢线的箭头一端的结点是该结点的后续结点。  Graph: The concept in the graph theory and the corresponding computer algorithm. A diagram is used to abstractly represent a set of objects (o ect) called vertices or nodes, some of which have links, called edges or lines (lme). A sequence of nodes that are wired together between nodes is called a path. A set of nodes in a graph, if its edges exist only within the set of nodes, then the set of nodes and their edges form a subgraph of the graph. If all the lines in a graph are directional, the graph is a directed graph whose edges are also called arcs or arrows. The node at the end of the arrow of all the vector lines starting at a node is the subsequent node of the node.
免疫程序(immumzation schedule); 指免疫接种实施规则和方法。 免疫程序 包括了应接受免疫接种的接种对象以及接种对象应接种的疫苗、剂量次数、各剂 次接种时的接种对象的年龄范围、各剂次接种间的时间间隔、和接种途径等信息。 免疫程序中 于确定接种对象以及接种对象何时应接受何种疫苗、如何接种该疫 苗的信息在本说明也称为条件信息。接种对象依据免疫程序规定完成针对一种疾 病的剂量次数即完成了针对该种疾病的免疫接种。免疫程序关于一剂次接种的条 件信息, 包括接种者接种时的年龄、可选 ^的疫苗、与其它已接受的接种间的时 间间隔等, 是可以用一组条件表示, 接种者是否应接种该剂次接种, 依赖于这些 条件是否能够满足。  Immunization schedule (immumzation schedule); refers to immunization implementation rules and methods. The immunization program includes the vaccination target to be vaccinated, the vaccine to be vaccinated, the number of doses, the age range of the vaccinated subjects at each dose, the interval between vaccinations, and the route of vaccination. The information in the immunization program to determine which vaccine to vaccinate and which vaccine to receive, and how to inoculate the vaccine is also referred to as conditional information in this description. The vaccination object completes the immunization against the disease by completing the dose number for one disease according to the immunization program. Immunization program Information on the condition of a single dose of vaccination, including the age at which the vaccinator is vaccinated, the optional vaccine, and the time interval between other accepted vaccinations, etc., can be expressed in a set of conditions, whether the vaccinator should be vaccinated The dose of this dose depends on whether these conditions can be met.
免疫程序图(immrniization schedule graph, ISG): 指用图来表示的免疫程序, 包括用图结构组织的免疫程序数据, 及相应的计算机算法。  Immrniization schedule graph (ISG): Refers to the immune program represented by a graph, including immune program data organized by graph structure, and corresponding computer algorithms.
接种信息处理: 根据免疫程序、 对接种者信息进行的分析处理及处理结果。 接种者是疫苗的接受者, 对应于免疫程序中的一个接种对象个体。接种者信息是 接种者与免疫接种有关的信息包括接种者个体的信息, 如接种者的年龄、 性别, 和接种者的接种信息, 如接种者的接种史等。接种者的接种史是该接种者所接受 的所有疫苗注射,一次注射包括了接种者接种的疫苗及接种该疫苗的日期。免疫 程序的一剂次接种的信息包含一些条件,接种者的一次注射是否对应于该剂次接 种, 依赖于接种者信息及该次注射是否能够满足该剂次接种的条件。如果一次注 射对应干免疫程序的一剂次接种, 则该注射是有效接种, 否则是无效接种。 系:指本说明中使用的一个概念。 与免疫程序相关的一些信息可按免疫接种 所防范的疾病种类分组,称为系:系可以有与其相应的疾病相同的名称,如 HepA 系。如果将疫苗按系分组 ϋ不考虑含减毒灭活疫苗接种时间间隔规定时, 免疫程 序可以是各系相互独立的,即在处理完含减毒灭活疫苗的注射或接种后接种者的 接种史—可以按系单独处理。 一个系也可以是合并几个系而得到的, 倒如 MMR系 使 联合疫苗 MMR时, 只要如前所述可以单独处理此系。免疫程序规定有些系 在超过一定的年龄 Ατ后, 接种者无需接种该系的疫苗。 例如: ffib系的推荐的接 种年龄范围是 [2月齢, 59月龄], Ατ=59月齢,接种者年龄超过 59月龄则无需 Hib 接种。 在本说明中, 这一年龄 Ατ定义为该系的截止年龄。 Vaccination information processing: Analytical processing and processing results based on immunization procedures, information on vaccinators. The vaccinator is the recipient of the vaccine, corresponding to one of the vaccinated individuals in the immunization program. The vaccinator information is information related to the vaccination of the vaccinator including information of the individual of the vaccinator, such as the age, sex of the vaccinator, and vaccination information of the vaccinator, such as the vaccination history of the vaccinator. The vaccination history of the vaccinator is all vaccination received by the vaccinator, and one injection includes the vaccine vaccinated by the vaccinator and the date of vaccination. The information on the one-time vaccination of the immunization program contains conditions under which the vaccinator's one injection corresponds to the vaccination, depending on the vaccinator information and whether the injection satisfies the conditions of the vaccination. If one injection corresponds to one dose of the dry immunization program, the injection is effectively vaccinated, otherwise it is ineffective. Department: Refers to a concept used in this description. Some of the information related to the immunization program can be grouped according to the type of disease that the immunization is guarded against, called a line: the system can have the same name as its corresponding disease, such as the HepA line. If the vaccines are grouped according to the system, regardless of the time interval for the inoculation of inactivated vaccination, the immunization schedule may be independent of each other, ie, the vaccination of the vaccinated person after the injection or vaccination with the attenuated inactivated vaccine is processed. History - can be handled separately by department. A line can also be obtained by combining several lines. For example, when the MMR system makes the combined vaccine MMR, the line can be treated separately as described above. Some provisions of the immunization program in the Department of more than a certain age Α τ, the department vaccinated do not need the vaccine inoculation. For example: The recommended vaccination age range for the ffib line is [February 齢, 59 months of age], Α τ = 59 齢, and the vaccination is over 59 months of age and does not require Hib vaccination. In this description, this age Α τ is defined as the cut-off age of the department.
元疫苗 (Atom Vaccine): 指本说明中使用的一个概念, 元疫苗是疫苗产品 中针对一种疾病的组分, 例如针对一种疾病的免疫原或免疫效应物质。为使接种 程序可以系相互独立, 一个联合疫苗 (combination vaccine) 可以被分解成多个 元疫苗, 即含有联合疫苗的一剂次接种可分为数剂次含元疫苗的接种,每一剂次 元疫苗接种含一种元疫苗; 含有联合疫苗的一次注射可分为数次含元疫苗的注 †算机 (cominiter): 是自然意义上的计算机, 例如个人†算机 (PC) ,也可 以是移动智能电话、 个人数据助手(PDA)或超级 算机, 通常由通过某种形式 的通信总线 Bus)连接在一起的多个功能单元, 如处理器(CPU)、 内存(RAM、 ROM), 输入输出设备、 各式存储媒介的外部存储、 有线或无线网络通信设备等 构成。 在其上通常运行有操作系统 (OS) 及应用软件程序。 应用程序的编码指 令存储在计算机可读媒介上, 在该程序运行时, 该程序的指令被加载入计算机的 存储器中并被执行, 提供该应用程序所实现的方法的功能。实现一个方法的应用 程序可以是一些可执行的程序, 也可以是集成在一起的或分开的软件模块  Atom Vaccine: A concept used in this description. A meta-vaccine is a component of a vaccine product that targets a disease, such as an immunogen or immune effector for a disease. In order to make the vaccination procedures independent of each other, a combination vaccine can be broken down into a plurality of meta-vaccinations, that is, one dose of vaccination containing the combined vaccine can be divided into vaccination of several doses of the primordial vaccine, each dose of the vaccination Vaccination with a one-way vaccine; a single injection containing a combination vaccine can be divided into several injections of a vaccine containing a dollar vaccine (cominiter): a computer in the natural sense, such as a personal computer (PC), or mobile A smart phone, personal data assistant (PDA) or supercomputer, usually connected by multiple functional units connected by some form of communication bus Bus, such as a processor (CPU), memory (RAM, ROM), input and output The device, external storage of various storage media, wired or wireless network communication devices, and the like. There are usually operating systems (OS) and application software programs running on them. The application's encoding instructions are stored on a computer readable medium, and when the program is run, the program's instructions are loaded into the computer's memory and executed to provide the functionality of the method implemented by the application. An application that implements a method can be either an executable program or an integrated or separate software module.
(modular) , 架构 (framework), 并提供有应用程序接口 (API), 通过 API向其 他程序提供其所实现的方法的功能。  (modular), architecture (framework), and provides an application programming interface (API) that provides the functionality of the methods it implements to other programs through the API.
集合: 涉及计算机领域的集合序列的数据结构及算法, 倒如列表(Ust)。在 对集合中的每一元素进行处理时,通常以一种循环的方式、依元素的存储位置来 依次读取集合中的每一元素, 赋给一个变量, 然后处理该变量的内容; 在循环过 程中,通常要用到判断是否尚有下一元素的操作, 即是否已到达集合序列的尾的 操作来确定遍历循环是否应结束;如有下一元素则读取该下一元素进行相应的处 理:如没有則退出循环,即对该集合的所有元素已进行了处理。作为具体的说明, 本说明中是否尚有下一元素或未处理的元素的操作相当于 Java集合架构 (J a Collection Framework) 中的 Iterator (迭代器)接口类中的 hasNext ( ) 操作, 读 取下一元素的操作相当于该 Iterator的 next ( ) 操作。 应该理解的是, 熟悉计算 机领域的人员可以采用任何集合数据结构存储、采用任何遍历方式来遍历处理本 说明中的集合中的元素。 Collection: Data structures and algorithms involving collection sequences in the computer domain, as in the list (Ust). When processing each element in the collection, each element in the collection is sequentially read in a loop, according to the storage location of the element, assigned to a variable, and then the content of the variable is processed; In the process, it is usually used to determine whether there is still an operation of the next element, that is, whether the end of the set sequence has been reached. The operation determines whether the traversal loop should end; if there is a next element, the next element is read for corresponding processing: if not, the loop is exited, that is, all elements of the set have been processed. As a specific description, whether the operation of the next element or the unprocessed element in this description is equivalent to the hasNext ( ) operation in the Iterator (Interceptor) interface class in the Java Collection Architecture (J a Collection Framework), reads The operation of the next element is equivalent to the next ( ) operation of the Iterator. It should be understood that those skilled in the computer arts may employ any arbitrarily structured data store to traverse the elements of the set in this description in any traversal manner.
实施倒 I:  Implementation I:
图 1是本发明实施例免疫程序可视化方法的框图示意图。 免疫程序的一剂 次接种及其属性,包括接种该剂次时所应满足的条件信息,用有向图 100中的一 个结点 101、 103、 105 106表示; 一剂次接种的结点 101与表示其下一剂次接种 的结点 103间用矢线〗 02连接, 矢线箭头指向该下一剂次接种的结点 103, 即结 点 101表示该两剂次接种中的前一剂次接种, 结点 103则表示下一剂次接种。结 点 101的后续结点 103、 105是结点 101所表示的一剂次接种的所有可能的下一 剂次接种对应的结点。矢线 104始干终于同一结点〗05用于表示定期重复加强接 种 (booster dose:)。 始结点 (siart node) 101表示图 100所表示的免疫程序的一 个第一剂次接种, 终结点 (end node) : 06表示该免疫程序的一个最后一剂次接 种。 一个免疫程序图可以有多个始结点或终结点, 从一个始结点至一个终结点的 路径表示完成该免疫程序图所表示的免疫程序中针对一种疾病的免疫接种的一 个可能的方式。 例如至少在非联合疫苗的情况下, 路径 i0i-103- 106表示需要 3 剂次接种完成有向图 100即免疫程序图 100所表示的免疫程序要求的免疫接种。 一个免疫程序图可以有多个路径表示完成免疫接种的可能方式。  1 is a block diagram showing a method for visualizing an immune program according to an embodiment of the present invention. One dose of vaccination of the immunization program and its attributes, including conditional information that should be met when the dose is inoculated, is represented by a node 101, 103, 105 106 in the directed graph 100; a node 101 inoculated with one dose Connected to the node 103 indicating the next dose of the inoculation with a vector line 02, the vector arrow points to the node 103 of the next dose, ie, node 101 represents the previous dose of the two doses. Sub-vaccination, node 103 indicates the next dose of vaccination. Subsequent nodes 103, 105 of node 101 are the corresponding nodes for all possible next doses of a single dose of vaccination represented by node 101. The vector line 104 is finally dry and the same node is used to indicate the periodic booster dose:. A siart node 101 represents a first dose of vaccination of the immunization program represented by Figure 100, and an end node: 06 indicates a last dose of the immunization program. An immune program map can have multiple start nodes or endpoints. The path from a start node to an endpoint indicates a possible way to complete the immunization against a disease in the immunization program represented by the immune program map. . For example, at least in the case of a non-combined vaccine, the route i0i-103-106 indicates that three doses of vaccination are required to complete the immunization required by the immunization program shown in Figure 100, the immunological program map 100. An immune program map can have multiple pathways indicating possible ways to complete immunization.
免疫程序图(ISG)的使用就是在 ISG中选择一个或数个路径使接种对象按 其完成免疫程序规定或推荐的针对各种疾病的免疫接种。  The use of an immunological program map (ISG) is to select one or several pathways in the ISG to vaccinate the vaccinated subject against various diseases as specified or recommended by the immunization program.
一系的 ISG可以是由与该系的疫苗相关的一个或多个免疫程序子图构成; 在一系的 ISG中, 一个接种对象只要完成一条从一个始结点至一个终结点的路 径, 就完成了该系的免疫接种。 完整的 ISG可以是 ffl各系的: SG作为子图构成。  A series of ISGs may be composed of one or more immune program subgraphs associated with the vaccine of the system; in a series of ISGs, an inoculation object only needs to complete a path from a starting node to an ending point. The immunization of the line was completed. The complete ISG can be of the ffl system: SG is composed of subgraphs.
使 一系 ISG选择一个路径的方法包括根据一个接种者的对应于该系的接 种史确定代表该接种史的路径, 这一过程被称为评估(Eva!uaiiOii)。 评估方法是 为该接种史中的每一次注射在该系的 G中根据各结点的接种条件信息寻找和 A method of selecting a path for a line of ISGs includes determining a path representative of the history of vaccination based on a vaccination history of a vaccinator corresponding to the line, a process referred to as assessment (E va !uaiiOii). Evaluation method is For each injection in the vaccination history, in the G of the line, according to the vaccination condition information of each node,
确定一个结点, 如果为一次注射找到了一个结点, 则这一次注射是有效接种。在 评估结束后, 如果该系的免疫接种尚未完成, 则代表该接种史的路径中的最后一 个结点可以 ]¾来确定该接种者所需的未来的接种,该结点的任一后续结点代表了 该接种者可以采^的下一次接种,该结点的后续结点可以用来确定该接种者所需 的且可以采 的该系的未来的接种, 这一过程被称为推荐 ( Recommendation)。 Determine a node. If a node is found for an injection, this injection is effectively vaccinated. At the end of the assessment, if the immunization of the line has not been completed, the last node in the path representing the history of the inoculation can be used to determine the future inoculation required by the inoculator, any subsequent knot of the node. The point represents the next vaccination that the vaccinator can take, and the subsequent node of the node can be used to determine the future vaccination of the line that the vaccinator needs and can take. This process is called recommendation ( Recommendation).
图 2是本发明实施例 iSG的数据结构 200的框图示意图。 数据结构 200用  2 is a block diagram of a data structure 200 of an iSG in accordance with an embodiment of the present invention. Data structure 200
来存储免疫程序图的一个结点及其后续结点的信息,这一数据结构可以用于建立 免疫程序图及用于接种信息处理。该数据结构包括以下数据元素: 唯一地识别该 结点的识别符 201 ; 该结点所对应的一剂次接种的信息剂信息 202, 包括接种该 剂接种的条件信息 233 ; 该剂次接种的下一剂次接种信息后续结点信息 203。 To store information about a node of the immune program map and its subsequent nodes, this data structure can be used to establish an immune program map and for vaccination information processing. The data structure includes the following data elements: an identifier 201 that uniquely identifies the node; a dose information information 202 corresponding to the dose of the dose corresponding to the node, including condition information 233 inoculated with the agent; The next dose of vaccination information is followed by node information 203.
条件信息 233可以是一组约束条件 204。下面是一剂次接种的约束条件的例 子及其描述- 疫苗 207 本剂次接种的疫苗; 可以是元疫苗代码 209, 也可以是普通的疫 ¾ 代码 213。  Condition information 233 can be a set of constraints 204. The following are examples of the constraints of a single dose of vaccination and their description - Vaccine 207 This dose of vaccine is vaccinated; it can be a meta-vaccine code 209, or it can be a common plague code 213.
许可使 ffi日期范围 疫苗的许可使用日期范 ί簡, 由起始及结束日期确定。  Licensing allows ffi date range The license's license usage date is determined by the start and end dates.
220  220
最小年齢范围 本剂次接种允许的接种对象的最小年齢范围, 由起始及结束曰期 确定, 通常只用起始日期。 通常只用于评估。  Minimum annual range The minimum annual range of vaccinated subjects allowed for this dose of vaccination is determined by the start and end periods, usually only the start date. Usually used only for evaluation.
最小时间间隔 本剂次接种时间距前一剂次接种时间的最小时间间隔要求。 通常 只用于评估。  Minimum time interval The minimum time interval between the dose of the dose and the time of the previous dose. Usually used only for evaluation.
最小时间间隔 ί 本剂次接种时间与再前一剂次接种时间的最小^间间隔要求。 推荐年龄范围 本剂次接种的推荐的接种对象的年龄范围, 由起始及结束日期确 定, 通常只用起始日期。 通常只 ^于推荐。  Minimum time interval ί The minimum interval between the dose of the dose and the time of the previous dose. Recommended Age Range The recommended age range for the vaccination for this dose is determined by the start and end dates, usually using only the start date. Usually only recommended.
推荐时间间隔 本剂次接种时间距前 ·剂次接种 间的推荐的时间间隔要求。 通 常只用于推荐。  Recommended Interval The recommended interval between the dose of the dose and the time before the dose. Usually only for recommendations.
可选接种 218 接种对象接受前一剂次接种的时间如果是在某一特定年龄内, 则 该接种对象应接受本剂次接种。 相同疫苗 要求疫苗 207与前一剂次接种所用疫苗相同的疫苗。 Optional vaccination 218 The vaccinated subject should receive the vaccination for the time of the previous dose if it is within a certain age. The same vaccine requires vaccine 207 to be the same vaccine as the vaccine used in the previous dose.
评估用 本结点只用于一次注射是否对应于本结点的评估。  Evaluation Use This node is only used for an injection that corresponds to the evaluation of this node.
推荐用 本结点只用于接种对象的 一剂次接种的推荐。  It is recommended to use this node only for the recommendation of one dose of vaccination.
女性用 本剂次接种为女性接种者设置。 为 HPV系设置。 人类乳突病毒  Women are vaccinated with this dose for female vaccinators. Set for the HPV system. Human papillomavirus
( Human Papilloniavims )  ( Human Papilloniavims )
优先疫苗 如接种对象尚未接种该优先疫苗, 则该优先疫苗应被优先推荐为 本剂次接种疫苗。为 Tdap系设置。通常应与前述推荐用约束条倂 共同使用。 破伤风-白喉-百日咳 ( Tdap=Tetanus , Diphtheria anc Pertussis} 出生日期范围 接种对象的出生日期范圈, ώ起始及结束日期确定; 为 MMR系 设置。 麻疹、 腮腺炎和风疹 (MMR:::Measles, mumps and rabei!a) 有效日期范围 221 本结点的有效日期范围, 由起始及结束日期确定。 用于免疫程序 的改变历史的标记, 即一剂次接种的条件有适 日期。  Priority vaccine If the priority vaccine has not been vaccinated, the priority vaccine should be recommended as the vaccine. Set for the Tdap system. It should normally be used in conjunction with the aforementioned recommended restraint strips. Tetanus-Diphtheria-Pertussis (Tdap=Tetanus, Diphtheria anc Pertussis} Date of birth range The date of birth of the vaccinated subject, determined by the start and end dates; set for the MMR system. Measles, mumps and rubella (MMR::: Measles, mumps and rabei! a) Effective Date Range 221 The effective date range for this node, determined by the start and end dates. The mark used to change the history of the immunization program, ie the conditions for a single dose of vaccination have a suitable date.
年龄范围 219 本剂次接种允许的接种对象的的年齢范围, 由起始及结束 期确 定。  Age range 219 The age range of the vaccinated subjects allowed for this dose is determined by the start and end periods.
其中疫苗 207约束条件可以是疫苗 210的代码 213或者源于疫苗 210的元 The vaccine 207 constraint may be the code 213 of the vaccine 210 or the element derived from the vaccine 210.
疫苗 208的代码 209。 疫苗 2i0用于存储一个疫苗的信息; 元疫苗 208用于存储 Code 208 for vaccine 208. Vaccine 2i0 is used to store information about a vaccine; meta-vaccine 208 is used for storage
一个元疫苗的信息 [:疫苗 210可以包含上述识别代码 2】3,许可使用时间范围 214, Information of a meta-vaccine [: vaccine 210 may contain the above identification code 2] 3, and the permitted use time range 214,
减毒灭活疫苗 215, 组分列表 216 (component Ust)。 组分列表 216是疫苗 210 Attenuated inactivated vaccine 215, component list 216 (component Ust). Component list 216 is vaccine 210
的每个组分,组分列表 2】6中的每一组分可以是该组分的名称 217及所属系 2】2。 Each component of the component list 2]6 may be the name of the component 217 and the associated system 2]2.
许可使用时间范围 214是疫苗 2】0的许可使用的日期范围。 减毒灭活疫苗 215 The license time range 214 is the date range for the licensed use of the vaccine 2]0. Attenuated inactivated vaccine 215
用于标出疫苗 210是否是减毒灭活疫苗。 元疫苗 208可以包含上述的识别代码 Used to indicate whether vaccine 210 is a live attenuated vaccine. The meta vaccine 208 can include the identification code described above
209, 以及疫苗代码 211 , 系 212。 其中疫苗代码 211及系 212是本元疫苗所对应 209, and vaccine code 211, is 212. Among them, vaccine code 211 and line 212 are corresponding to the original vaccine.
的疫苗 210的代码 213及组分的所属系 212。 The code 210 of the vaccine 210 and the component of the component 212.
在使用一组约束条件 204描述条件信息 233 , 在一系的 ISG中要使得任  The condition information 233 is described using a set of constraints 204, which is to be made in a series of ISGs.
一结点的任意两个后续结点的约束条件 204没有重叠, 郎: 两结点的相同的约束 条件中至少有一个其参数取值范圈是完全相斥的。例如作为约束条件的取值范 完全相斥的例子: 两结点疫苗约束条件 207不相同: 两结点的与时间相关的约束 条件如年龄范围 219等约束条件没有交集。在两个结点约束条件 204重迭的情况 下, 一剂次接种可能同^满足这两个结点的约束条件,这使得接种信息处理中对 接种史的评估变得复杂, 因此应避免出现这种情况。 The constraint 204 of any two subsequent nodes of a node does not overlap, Lang: the same constraint of the two nodes At least one of the parameters in the condition is completely exclusive. For example, the example of the value of the constraint is completely repelled: The two-node vaccine constraint 207 is different: the time-related constraints of the two nodes, such as the age range 219, do not intersect. In the case where the two node constraints 204 overlap, a dose of vaccination may satisfy the constraints of the two nodes, which makes the evaluation of the vaccination history in the vaccination information processing complicated, and therefore should be avoided. This is the case.
后续结点信息 203是后续结点对的列表 206, 其中一对 205当中的识别符 231是一个后续结点的识別符, 而优先级 232是该后续结点在该列表 206中所有 后续结点中的优先级,用于辅助确定各后续结点在接种信息处理中被选用的优先 图 3是本发明实施倒免疫程序计算机辅助设计系统(ISCAD) 300的框图示 意图。 ISCAD 300包括免疫程序辅助设计输入界面 301, 免疫程序存储 307。 这 些组件 301、 307可以是以集成在一起的或分幵的功能模块的方式实现, 由这些 功能模块构成的】SCAD 300应用程序通常与操作系统及其它应用程序一起储存 于计算机可读媒介上, 如硬盘上, 在该程序运行时, 该程序的指令被加载入计 算机的存储器中并被执行,使得该计算机能够帮助及引导用户输入和维护疫苗数 据, 以图形方式设计、 建立和维护免疫程序, 检验免疫程序及相关文档。  The subsequent node information 203 is a list 206 of subsequent node pairs, wherein the identifier 231 of the pair 205 is an identifier of a subsequent node, and the priority 232 is all subsequent nodes of the subsequent node in the list 206. The priority in the point is used to assist in determining the priority of each subsequent node selected in the vaccination information processing. FIG. 3 is a block diagram diagram of the computer aided design system (ISCAD) 300 of the present invention. The ISCAD 300 includes an immune program assisted design input interface 301, and an immune program storage 307. These components 301, 307 can be implemented in the form of integrated or distributed functional modules, and the SCAD 300 applications composed of these functional modules are usually stored on a computer readable medium together with an operating system and other applications. On the hard disk, when the program is running, the program instructions are loaded into the computer's memory and executed, so that the computer can help and guide the user to input and maintain vaccine data, graphically design, establish and maintain the immune program. Test the immunization program and related documentation.
免疫程序辅助设计输入界面 30 包括免疫程序对象管理模块 302,疫苗编辑 模块 303 , 元疫苗编辑模块 304, 免疫程序图编辑模块 305 , 免疫程序辅助设计 任务 306。作为改迸,免疫程序输入界面 301还集成有免疫程序出版发行引擎 308 用于发行 ISG。 The immune program assisted design input interface 30 includes an immune program object management module 302, a vaccine editing module 303, a meta vaccine editing module 304, an immune program map editing module 305, and an immune program assist design task 306. As a variant, the immunization program input interface 301 is also integrated with an immunization program publishing engine 308 for issuing ISGs.
免疫程序辅助设计输入界面 301可以与辅助设计任务 306协同用于有依赖 关系的数据的自动生成及完整性、 自洽性检验以及维护、 清理等。  The immune program assisted design input interface 301 can be used in conjunction with the auxiliary design task 306 for automatic generation and integrity of dependent data, maintenance, maintenance, cleanup, and the like.
用户可以使 免疫程序管理模块 302及其图形用户界面分类管理和添加、 删除、 复制、 粘贴、 搜索、 选择即编辑与免疫程序相关的对象, 从免疫程序存储 307中读入或向免疫程序存储 307写入免疫程序相关的对象数据。 图 4是本发明 实施例 iSCAD 300当一个疫苗被选中时的用户界面 400示意图。 用户界面 400 显示了对象管理模块 302的浏览器用户界面 401和疫苗编辑模块 303的疫苗创建 用户界面 402及 ¾户界面 301的输出信息浏览器 407。浏览器用户界面 401用于 组织管理免疫程序相关的对象。免疫程序相关的对象可以是以树状结构分类显示 在浏览器用户界面 40〗中, ]¾户可以按免疫程序相关的对象种类来搜索、管理免 疫程序相关数据及信息。倒如,树状结构的第一级节点可以是系 403或联合疫苗 404;在系节点 403之下可以是属于该系的对象的分类的节点 4i0-412;在眹合疫 苗节点 404之下可以是属于联合疫苗的对象的分类的节点 413- 4M; 在一个分类 节点 410-414下可以是属于该类的个别对象或实体,该节点本身也可以对应于该 分类的综合性对象或实体, 例如免疫程序节点 412可以对应于一系的 ISG, 而在 该节点 412下是该系个别疫苗的 ISG 405。 用户可以使用浏览器用户界面 401向 树上添加、 删除、 复制、 粘贴、 搜索、 选择即编辑一系 403、 联合疫苗 404、 一 类对象的分类节点 4i0- 414或个别对象或实体 405-406。 The user can enable the immune program management module 302 and its graphical user interface to classify and manage, add, delete, copy, paste, search, select, edit, and edit objects related to the immune program, and read from the immune program storage 307 or store the immune program 307. Write object data related to the immunization program. 4 is a schematic diagram of a user interface 400 when an iSCAD 300 is selected as a vaccine in accordance with an embodiment of the present invention. The user interface 400 displays the browser user interface 401 of the object management module 302 and the vaccine creation user interface 402 of the vaccine editing module 303 and the output information browser 407 of the user interface 301. The browser user interface 401 is used to organize and manage immune program related objects. Immune program related objects can be displayed in a tree structure In the browser user interface 40, the user can search and manage the immune program related data and information according to the type of the object related to the immunization program. For example, the first level node of the tree structure may be the system 403 or the combination vaccine 404; under the system node 403 may be the classified nodes 4i0-412 belonging to the object of the system; under the combined vaccine node 404 Is a node 413-4M belonging to the classification of the object of the combined vaccine; under a classification node 410-414 may be an individual object or entity belonging to the class, the node itself may also correspond to the comprehensive object or entity of the classification, for example Immune program node 412 may correspond to a series of ISGs, and under this node 412 is an ISG 405 for the individual vaccines of the system. The user can add, delete, copy, paste, search, select, edit a family 403, a combined vaccine 404, a class of object classification nodes 4i0-414, or individual objects or entities 405-406 to the tree using the browser user interface 401.
当一个对象 405-406、 410- 414在免疫程序管理模块 302中被选中时, 如果 有编辑模块与该对象相对应,则用户可以使 ffl所对应的编辑模块编辑该对象的数 据。 飼如, 当一个疫苗 406被选中时, 该疫苗的数据显示在疫苗编辑模块的用户 界面 402中。用户可以使用用户界面 402输入或编辑疫苗的各属性值。当一个对 象 405-406、 410- 414被选中时, 如果在辅助设计任务模块 306中有与该对象相 对应的处理任务 (task), 则用户可以使用该相应的处理任务处理被选中的对象, 处理过程中生成的免疫程序相关的对象数据将交由对象管理模块 302管理,并将 显示在界面 401中。例如, 当一个疫苗 406被选中 , 用户可以选择使用辅助设 ^任务模块 306的 ώ疫苗生成元疫苗处理任务,例如使用用户界面 301的工具条 408 , 由疫苗 406生成元疫苗。 从一个疫苗生成元疫苗的方法是: 一个疫苗的每 一组分应该产生一个元疫苗, 该元疫苗的系是该组分的系, 该元疫苗的其他参数 值可以是该疫苗相应的参数值。  When an object 405-406, 410-414 is selected in the immune program management module 302, if an editing module corresponds to the object, the user can cause the editing module corresponding to ffl to edit the data of the object. Feeding, when a vaccine 406 is selected, the vaccine's data is displayed in the user interface 402 of the vaccine editing module. The user can enter or edit various attribute values of the vaccine using the user interface 402. When an object 405-406, 410-414 is selected, if there is a processing task corresponding to the object in the auxiliary design task module 306, the user can use the corresponding processing task to process the selected object. The immune program related object data generated during the processing will be managed by the object management module 302 and will be displayed in the interface 401. For example, when a vaccine 406 is selected, the user may elect to use the sputum vaccine to generate a meta-vaccine processing task, such as using the toolbar 408 of the user interface 301 to generate a meta-vaccine from the vaccine 406. The method for generating a meta-vaccine from a vaccine is: Each component of a vaccine should produce a meta-vaccine, the meta-vaccine is the line of the component, and the other parameter value of the vaccine can be the corresponding parameter value of the vaccine. .
输出信息浏览界面 407用于 ISCAD 300各模块输出信息的显示、 浏览及阅 读。  The output information browsing interface 407 is used for displaying, browsing, and reading the output information of each module of the ISCAD 300.
图 5是本发明实施例 ISCAD 300当元疫苗 502被选中时的用户界面 500示 意图。 ^户界面 500显示了元疫苗编辑模块 304的用户界面 501。 被选中的元疫 苗 502的属性值显示在用户界面 50】中, 用户可以使用界面 501输入、删除、修 改即编辑元疫苗的各属性值。  Figure 5 is a schematic illustration of user interface 500 when ISCAD 300 is selected as a meta-vaccine 502 in accordance with an embodiment of the present invention. The user interface 500 displays the user interface 501 of the meta vaccine editing module 304. The attribute value of the selected plague 502 is displayed in the user interface 50], and the user can use the interface 501 to input, delete, modify, and edit the attribute values of the meta vaccine.
本发明的一个实施倒是辅助设计任务模块 306可以包括疫苗免疫程序生成 任务模块,该任务模块可以根据预定义的模板自动生成一个疫苗或元疫苗的 ISG 框架 (skeleton), 供 j¾户进一歩编辑。 图 6显示了辅助设计任务模块 306的疫苗免 疫程序生成任务 606被选中时的用户界面的示意图[用户可以使用系选择用户界 面 600选择一组疫苗 601, 可以是一系或眹合疫苗, 该组疫苗 601中的个体元疫 苗或疫苗 602将显示在疫苗剂量选择用户界面 603中,用户可以为每一个元疫苗 或疫苗 602输入该元疫苗或疫苗用于免疫接种的剂量次数 604。然后用户可以选 择, 例如使用按钮 605, 生成各元疫苗或疫苗 602的 ISG的框架, 用于进一歩的 编辑。 生成的 ·个元疫苗或疫苗 602的 iSG框架可以有与输入的剂量次数 604 相同数量的结点,每一结点将有该元疫苗或疫苗 602的识别符 209或 213作为疫 苗约束条件以及从该元疫苗或疫苗 602导出的或在预定义的模板中定义的一些 约束条件及其值,如从元疫苗或疫苗许可时间范围 214导出的许可使用日期范 220约束条件等。 One implementation of the present invention is that the assisted design task module 306 can include a vaccine immunization program generation task module that can automatically generate a vaccine or meta-vaccine ISG based on a predefined template. Skeleton, for j3⁄4 households to edit. 6 shows a schematic diagram of the user interface when the vaccine immunization program generation task 606 of the assist design task module 306 is selected [ users can select a set of vaccines 601 using the system selection user interface 600, which may be a line or combination vaccine, the group The individual dose vaccine or vaccine 602 in vaccine 601 will be displayed in vaccine dose selection user interface 603, and the user may enter the number of doses 604 of the meta-vaccine or vaccine for immunization for each meta-vaccine or vaccine 602. The user can then select, for example, use button 605 to generate a framework for the ISG of each meta-vaccine or vaccine 602 for further editing. The generated iSG framework of the individual vaccine or vaccine 602 may have the same number of nodes as the number of doses 604 entered, each node will have the identifier 209 or 213 of the vaccine or vaccine 602 as a vaccine constraint and Some of the constraints and values derived from the meta-vaccine or vaccine 602 or defined in a predefined template, such as the license use date 220 constraint derived from the meta-vaccine or vaccine license time range 214, and the like.
用户可以使用对象管理模块 302的 ]¾户界面 401选择 ·系 iSG或个别疫苗 或个别元疫苗的】SG用编辑模块 304进行编辑。图 7是本发明实施^ ISCAD 300 当一系的 ISG 703被选中时的 ^户界面 700示意图。 ^户界面 700显示了编辑模 块 304的 ISG创建用户界面 701 ,约束条件选择用户界面 702。被选中的 iSG 703 将显示在用户界面 701中。 用户可以使用 ISG编辑工具条 705添加新的结点- 在结点间连矢线, 例如线 706; 编辑线的优先级; 复制、 剪裁、 粘贴、 删除图中 被选中的包括结点、 线及约束条件等 ISG图形元素及数据。 例如, 当编辑线 706 的优先级时, 用户可以选择该线 706, 然后使用编辑工具条 705中的下拉列表选 择所需的优先级赋予该线 706, 不同的优先级值可以用不同的线条样式 (line style) 表示。 当用户要向一个结点 710中添加一个约束条件时', 例如年龄范围约 束条件, ^户可以选择在约束条件列表 702中选择该约束条件,将其拖放到该结 点 710, 该约束条件将被加入到该结点 710中。 ¾户也可以选择从一个结点中复 制一个约束条件 709然后粘贴到另一结点 710中。用户可以使用约束条件编辑界 面 708, 例如通过使用鼠标双击结点 707激活约束条件编辑界面 708, 编辑约束 条件的各属性变量的值。 弹出式信息窗 711, 用于浏览一个约束条件 709的详细 属性。  The user can select the iSG or individual vaccine or individual vaccine for the SG with the editing module 304 of the object management module 302. Figure 7 is a schematic diagram of the UI interface 300 of the present invention when the ISG 703 of a system is selected. The user interface 700 displays the ISG creation user interface 701 of the editing module 304, and the constraint selection user interface 702. The selected iSG 703 will be displayed in the user interface 701. Users can use the ISG Editing Toolbar 705 to add new nodes - arbitrage between nodes, such as line 706; edit line priority; copy, crop, paste, delete selected nodes including nodes, lines and ISG graphical elements and data such as constraints. For example, when editing the priority of line 706, the user can select the line 706 and then use the drop down list in the edit toolbar 705 to select the desired priority to assign to the line 706. Different priority values can be used with different line styles. (line style) indicates. When the user wants to add a constraint to a node 710, such as an age range constraint, the user may choose to select the constraint in the constraint list 702 and drag and drop it to the node 710, the constraint Will be added to this node 710. The household can also choose to copy a constraint 709 from one node and then paste it into another node 710. The user can edit the interface 708 using constraints, such as by using the mouse to double-click the node 707 to activate the constraint editing interface 708, editing the values of the various attribute variables of the constraint. A pop-up information window 711 for browsing the detailed attributes of a constraint 709.
本发明的一个实施倒是辅助设计任务模块 306可以包括后续结点疫苗使用 分析任务模块。 用户可以在用户界面 301上, 例如使用工具条 7】2, 选择该任务 模块为在用户界面 70〗中被选中的一个结点,在输出信息浏览器 407中列出该结 点的后续结点中出现以及还没有出现过的同一系的元疫苗的信息,比如元疫苗的 识别符及其名字,用户可以检查并考虑 没有出现过的元疫苗作为该结点的后续 结点的疫苗 207的可能性。 One implementation of the present invention is that the auxiliary design task module 306 can include a subsequent node vaccine usage analysis task module. The user can select the task on the user interface 301, for example using the toolbar 7]2. The module is a node selected in the user interface 70. The output information browser 407 lists information about the same type of meta-vaccine that appears in the subsequent nodes of the node and has not yet appeared, such as a meta vaccine. The identifier and its name, the user can check and consider the possibility of a non-existing meta-vaccine as a vaccine 207 for the subsequent node of the node.
本发明的一个实施倒是辅助设计任务模块 306可以包括后续结点重迭分析 任务模块。 用户可以在用户界面 301上, 例如使用工具条 713, 选择该任务模块 为在用户界面 701中被选中的一个结点,在输出信息浏览器 407中列出该结点的 后续结点中是否存在有两个结点约束条件 204重迭的情况。用户可以检查在输出 信息浏览器 407中列出的约束条件重迭结点的信息,并考虑避免出现后续结点中 结点约束条件 204重迭的情况下建立免疫程序的可能性。  One implementation of the present invention is that the auxiliary design task module 306 can include a subsequent node overlap analysis task module. The user can select the task module as a node selected in the user interface 701 on the user interface 301, for example, using the toolbar 713, and list whether the subsequent nodes of the node exist in the output information browser 407. There are two cases where the node constraints 204 overlap. The user can check the information of the constraint overlap nodes listed in the output information browser 407 and consider the possibility of establishing an immune procedure in the event that the node constraints 204 overlap in subsequent nodes.
本发明的一个实施倒是辅助设计任务模块 306可以包括相关数据维护、 检 验、 清理任务模块。 ]¾户可以在用户界面 30】上, 例如使用工具条 714, 选择该 任务模块检验免疫程序包括疫苗、 元疫苗、 SG的数据格式、 数据间依赖关系、 数据值有效范围等。 辅助设计任务模块 306的相关数据维护、检验、清理任务模 块也可以与其它模块合作自动完成免疫程序的维护。例如当一个疫苗在浏览器用 户界面 40】 中被选中并 ffi除时, 辅助设计任务模块 306的相关数据维护、 检验、 清理任务模块可以查找依赖此疫苗的对象,例如依赖此疫苗的元疫苗以及依赖此 疫苗的: SG的结点, 如果发现了有依赖于此疫苗的对象, 则在用户界面 301中 显示数据依赖关系的提示警告信息, 如以弹出式会话窗方式,请求用户确认该 删除操作应包含依赖该疫苗的对象。 One implementation of the present invention is that the auxiliary design task module 306 can include associated data maintenance, inspection, and cleanup task modules. The user can select the task module on the user interface 30, for example, using the toolbar 714 to verify the immunization program including the vaccine, the meta vaccine, the data format of the SG, the inter-data dependencies, the valid range of the data values, and the like. The related data maintenance, inspection, and cleaning task modules of the auxiliary design task module 306 can also automatically complete the maintenance of the immune program in cooperation with other modules. For example, when a vaccine is selected and ffi removed in the browser user interface 40 ], the associated data maintenance, inspection, and cleanup task module of the auxiliary design task module 306 can look up objects that depend on the vaccine, such as a meta-vaccine that relies on the vaccine, and Depending on the SG node, if an object dependent on the vaccine is found, a prompt warning message indicating the data dependency is displayed in the user interface 301, for example, in a pop-up session window manner, the user is requested to confirm the deletion operation. It should contain subjects who depend on the vaccine.
本发明的一个实施倒是免疫程序管理模块 302可以包含一个基于免疫程序 相关对象的动态菜単、工具条生成及管理系统,可以根据用户所选对象 403-406、 410-414, 生成及管理基于被选中的对象的一些任务菜单、 工具条引导用户完成 一些相关的任务。  One implementation of the present invention is that the immune program management module 302 can include a dynamic recipe, toolbar generation and management system based on the immune program related objects, which can be generated and managed based on the selected objects 403-406, 410-414 of the user. Some task menus and toolbars of the selected objects guide the user through some related tasks.
免疫程序出版发行引擎 308用于各种格式的免疫程序的出版发行。 免疫程 序出版发行引擎 308可以是集成在免疫程序用户界面 30〗中。用户可以在用户界 面 301上, 例如使用工具条 715, 选择出版发行引擎 308 , 以用户选择的格式发 行、 转换、 输出免疫程序。 出版发行引擎 308将从免疫程序存储 307读入数据、 转换到 ]¾户所选格式并输出免疫程序,例如后面配合图 8将会进 ·步描述的以图 形的格式出版免疫程序供普通读者用户使用; 以及以 XML文档格式出版免疫程 序供传送至接种信息处理服务系统并被该系统使用 [:用户可以选择单一或数个疫 苗或元疫苗、 单一系或数个系的 ISG出版发行。 用户可以改变免疫程序发行的 缺省格式, 例如使用输入界面 301中系统的菜单设置发行的缺省格式。 The immunization program publishing engine 308 is used for the publication of immunization programs in various formats. The immunization program publication engine 308 can be integrated into the immunization program user interface 30. The user can select, on the user interface 301, for example, using the toolbar 715, the publishing engine 308 to issue, convert, and output the immunization program in a format selected by the user. The publishing engine 308 will read the data from the immune program storage 307, convert it to the selected format, and output the immune program, for example, as described later in conjunction with FIG. The format of the publication of the immunization program for the average reader user; and the publication of the immunization program in XML document format for transmission to the vaccination information processing service system and used by the system [: users can choose single or several vaccines or meta-vaccines, single line or Several departments of ISG published. The user can change the default format of the immune program release, such as using the default format of the system's menu settings in the input interface 301.
图 8是本发明实施倒以图形格式发行的 ISG 800示意图。 ISG 800可以有多 个免疫程序框图 801及一个图例 803。 每一框图 801可以有一个或多个结点表 804; SG的一个结点, 飼如结点 707, 可以对应框图 801中的一个结点表, 例 如结点表 804; —个结点表能显示其所对应的结点的部分或所有约束条件。 每一 框图 80 可以有一个或多个注释 802, 用于列出该框图的一些信息, 例如该框图 用到的疫苗的信息, 以及该框图中的结点表间的共享信息。 图^ 803用于说明框 图 801中各字符、 符号及图形元素的含义。  Figure 8 is a schematic diagram of an ISG 800 issued in a graphical format in accordance with the present invention. The ISG 800 can have multiple immune block diagrams 801 and a legend 803. Each block diagram 801 can have one or more node tables 804; a node of the SG, fed as node 707, can correspond to a node table in block 801, such as node table 804; Show some or all of the constraints of the node it corresponds to. Each block diagram 80 may have one or more annotations 802 for listing some of the information of the block diagram, such as information about the vaccine used in the block diagram, and the shared information between the node tables in the block diagram. Figure 803 is used to illustrate the meaning of each character, symbol and graphic element in the frame 801.
图 9是本发明实施飼用于接种信息处理时存储处理过程的过程状态 1100的 一个数据结构》 过程状态 1100可以包括一般状态 1120及各系的状态 1123 ; — 般状态 1120中的推荐日期范围 1121 [Τ¾3Γ ίκ1]用于设定用户感兴趣的未来接种推 荐日期范围, 其中 Tsian是起始日期、 Tend是截止日期; 过程状态 1100中的状态 1124-〗126及 1128- 1129可以是以列表的方式实现, 状态 L127可以是一个布尔 (Boolean)变量, 当为 TRUE时表示该系的的接种已经完成, 为 FALSE时表示 尚未完成。 Figure 9 is a data structure of a process state 1100 of a storage process for use in inoculation information processing in accordance with the present invention. Process state 1100 can include a general state 1120 and states 1123 of the various systems; a recommended date range 1121 in the general state 1120. [Τ 3⁄43Γ ίκ1 ] is used to set the future vaccination recommendation date range of interest to the user, where T sian is the start date and T end is the due date; states 1124- 126 and 1128 - 1129 in process state 1100 may be The implementation of the list, the state L127 can be a Boolean variable, when it is TRUE, it indicates that the inoculation of the system has been completed, and when it is FALSE, it indicates that it has not been completed.
图 10 a) 是本发明实施例使用 ISG进行接种信息处理的方法的框图示意图。 在歩骤 200, 收到接种者信息, 开始处理该接种者信息。  Figure 10 a) is a block diagram showing a method for performing inoculation information processing using an ISG in the embodiment of the present invention. At step 200, the vaccinator information is received and the vaccinator information is processed.
在步骤〗201 , 过程状态 1100被初始化, 包括初始化状态 Π24-Π28, 例如 清空状态 1124-1126和 1128存储単元等, 和设置系结束标识符 1127为 FALSE 等。  In step 201, the process state 1100 is initialized, including initialization states Π24-Π28, such as clearing states 1124-1126 and 1128 storage units, etc., and setting the system end identifier 1127 to FALSE, and the like.
在步骤 1202, —些预处理任务需要抉行, 以便该接种者的接种史及其所需 的未来的接种可以逐系处理。 在这一歩骤内, 通常需要完成: 1 ) 转换接种者的 接种史中的各次注射成元疫苗注射, 转换的方法是从一次注射中的疫苗的代码 213及其组分列表 216来确定该疫苗所含的各个元疫苗, 然后由这些元疫苗及该 注射的 间生成元疫苗注射并存储在相应系的接种史 i i24中, 并可依注射日寸间 对接种史 1124中注射排序; 2 )检验含减毒灭活疫苗的元疫苗注射间的时间间隔 是否符合免疫程序规定, 不符合的注射是无效接种。预处理中被确定是无效接种 的注射及无效的理 被记录在已评估注射列表 1129中。 At step 1202, some of the pre-treatment tasks need to be performed so that the vaccination history of the vaccinator and the future vaccination required thereof can be processed step by step. Within this step, it is usually necessary to complete: 1) Convert each vaccination vaccination in the vaccination history of the vaccinator by changing the code 213 of the vaccine in one injection and its component list 216 Each of the meta-vaccines contained in the vaccine is then injected and stored in the vaccination history i i24 of the corresponding line by the meta-vaccine and the inter-injection primordial injection, and can be sorted according to the injection time 1124 in the injection time; 2 Check the time interval between the injections of the vaccination containing the attenuated inactivated vaccine Whether it meets the immunization program, non-conforming injections are invalid vaccinations. Injections and invalidation determined to be ineffective vaccination in the pretreatment are recorded in the evaluated injection list 1129.
在歩骤 1203 , 该接种者信息中的接种史及其未来所需的接种被逐系处理。 对一系的处理是应先评估该接种者的该系的接种史 1124, 然后确定该接种者在 推荐日期范围 1121内所需的该系的未来的接种, 并存储在该系的推荐接种 1126 内。 因为各系可以分开独立处理, 所以各系可以有不同的处理方法。对一系的处 理的方法将在后面结合图 10 b)详细 i寸论。  At step 1203, the vaccination history in the vaccinator information and the vaccinations required in the future are processed on a case-by-case basis. The treatment of a line should first assess the vaccination history of the line of the vaccinator 1124, and then determine the future vaccination of the line required by the vaccinator within the recommended date range 1121 and store the recommended vaccination 1126 in the line. Inside. Because the departments can be processed separately and independently, each department can have different processing methods. The method of processing a series will be described later in conjunction with Figure 10 b).
在步骤 1204, —些后处理任务需要执行。 在这一步骤內, 通常需要完成下 列任务: 1 )检查推荐接种 1126所包含的各含减毒灭活疫苗推荐接种间的时间间 隔及与接种者的接种史中各含减毒灭活疫苗的注射间的时间间隔是否符合免疫 程序的规定; 其中时间间隔不符合的推荐接种将被调整,通常是逐歩延后该推荐 接种的接种时间,直到延后的^间能与其它含减毒灭活疫苗的推荐接种的时间间 隔及接种者的接种史中各含减毒灭活疫苗的注射的时间间隔符合免疫程序的规 定- 如果处理报告中需要, 无法在推荐日期范圈 1121内调整接种时间的推荐接 种被记录; 2 ) 转换推荐接种中的元疫苗接种到疫苗接种, 转换的 ·个方法是如 果一个疫苗 210的组分列表 216中的所有组分对应的元疫苗出现在推荐接种中, ϋ这些元疫苗推荐接种中的接种时间有非空的交集,则用该疫苗及该时间交集生 成 ·个疫苗推荐接种; 推荐接种中无法转换的元疫苗接种应被记录; 3 ) 根据处 理状态 1100生成处理报告, 例如根据状态 1128-1129生成接种史评估报告及根 据状态 127确定是否生成推荐报告,如生成推荐报告则根据状态 1126生成未来 接种推荐报告;  At step 1204, some post-processing tasks need to be performed. Within this step, the following tasks are usually required: 1) Check the recommended interval between the recommended vaccinations for each of the attenuated inactivated vaccines included in the recommended vaccination 1126 and the vaccination history of the vaccinated person with attenuated inactivated vaccine Whether the time interval between injections meets the requirements of the immunization program; the recommended vaccination in which the time interval is not met will be adjusted, usually after the vaccination time of the recommended vaccination, until the delay between the vaccination and other detoxification The time interval between the recommended vaccination of the live vaccine and the vaccination history of the vaccinator includes the time interval for the injection of the attenuated inactivated vaccine. The immunization schedule is not met. The recommended vaccination is recorded; 2) Converting the vaccination in the recommended vaccination to vaccination, the conversion method is if a meta-vaccine corresponding to all components in the component list 216 of a vaccine 210 appears in the recommended vaccination, ϋIf the vaccination time in the recommended vaccination of these meta-vaccinations is non-empty, use the vaccine and the time to produce a vaccine recommendation. Vaccination; Meta-vaccination that cannot be converted during the recommended vaccination should be recorded; 3) Generate a treatment report according to the treatment status 1100, for example, generate a vaccination history evaluation report according to the state 1128-1129 and determine whether to generate a recommendation report according to the status 127, such as generating a recommendation report. Generating a future vaccination recommendation report based on state 1126;
在步骤 1205, 处理结束, 处理报告 1103被返回。  At step 1205, processing ends and processing report 1103 is returned.
图 10 b) 是本发明实施例对一系的一个处理方法的流程框图示意图。对一系 的处理始于步骤 1211。在步骤 1212, 赋值所有可能的后续结点集合 1125为所有 该系的始结点的集合。在步骤 1213-1214 ,如果该系接种史 1124中尚有未评估的 注射, 则评估该系接种史。 ^估接种史的方法是依接种时间先后次序为该系接种 史】 124中的没有出现在己评估注射列表 1129中的每一次注射在该系的 ISG中确 定一个结点; 如果无法为某一次注射找到一个结点, 则这一次注射应是一次无效 接种。 该次注射及评估结果可以被记录在该系的已评估注射列表 1128以便生成 处理报告。 在步骤 1215- 1216, 如果该系的免疫接种尚未完成, 则用在步骤 1214 评估该系的接种史 1124时所确定的路径中的最后一个结点的后续结点推导出该 接种者所需的未来的接种。在歩骤 1217,该系的处理结束,返回主流程控制 1203。 FIG. 10 b) is a block diagram showing a flow of a processing method for a system according to an embodiment of the present invention. The processing of a series begins at step 1211. At step 1212, all possible subsequent node sets 1125 are assigned as a set of all the starting nodes of the system. At steps 1213-1214, if there is an unevaluated injection in the vaccination history 1124, the vaccination history is evaluated. The method of estimating the history of vaccination is to determine the vaccination history according to the vaccination time. Each injection in 124 that does not appear in the evaluated injection list 1129 determines a node in the ISG of the system; Injecting to find a node, this injection should be an invalid vaccination. The injection and evaluation results can be recorded in the department's evaluated injection list 1128 for generation Process the report. At steps 1215-1216, if the vaccination of the line has not been completed, the subsequent node required for the last node in the path determined by assessing the vaccination history 1124 of the line at step 1214 is used to derive the desired amount for the vaccinator. Future vaccination. At step 1217, the processing of the system ends and returns to the main flow control 1203.
本发明实施例 ^估接种者一系的接种史 1124的一个方法, 这一方法可用于 步骤 1214评估一系的接种史, 所述方法有下列步骤;  DETAILED DESCRIPTION OF THE INVENTION A method for estimating the inoculation history of a vaccinator, 1124, which can be used in step 1214 to assess a vaccination history of a line, the method having the following steps;
a) 如果该系接种史 Π24中尚有未评估的注射',则依接种时间先后次序在该 接种史 1124中取下一未评估的注射; 否则该系评估结束, 退出该系 ^估处理; b) 检验该注射是否满足后续结点集合 1125中的某一个结点的所有约束条 件; 如果满足, 则该注射为有效接种, 添加该注射在已评估注射列表 1128中, 继续执行 c); 否則记录该注射为无效接种并添加该注射及无效原因在已评估注 射列表 1128中, 转去执行 a;  a) If there is an unevaluated injection in the vaccination history 24, the unevaluated injection is taken in the vaccination history 1124 according to the vaccination time sequence; otherwise, the evaluation ends and the system is withdrawn; b) verifying that the injection satisfies all of the constraints of one of the subsequent node sets 1125; if so, the injection is a valid vaccination, adding the injection to the evaluated injection list 1128, continuing with c); Recording the injection as an invalid vaccination and adding the injection and the cause of the invalidation in the evaluated injection list 1128, transferring to execution a;
c) 检查该有效接种所对应的结点是否是一个终结点; 如不是终结点, 则取 该结点的所有后续结点并赋给后续结点集合 1125 , 转去抉行 a): 如是终结点, 则设置该系的结束标识符 1127表示该系的免疫接种已完成, 退出该系评估。  c) Check if the node corresponding to the valid vaccination is an endpoint; if it is not the endpoint, take all subsequent nodes of the node and assign it to the subsequent node set 1125, and then go to a): If it is the end Point, then set the end identifier 1127 of the department to indicate that the immunization of the system has been completed, and exit the department evaluation.
在上述方法中, 步骤 b)中, 如果后续结点信息中有优先级信息, 则在检验 一个注射是否满足后续结点集合 1125中的某一个结点的所有约束条件时, 应 高优先级至低优先级取各结点检验该注射是否满足所取结点的所有约束条件。如 果后续结点信息中没有优先级信息,则可以任何顺序取各结点检验该注射是否满 足所取结点的所有约束条件。  In the above method, in step b), if there is priority information in the subsequent node information, when checking whether an injection satisfies all the constraints of one of the subsequent node sets 1125, the priority should be high. The low priority takes each node to check whether the injection satisfies all the constraints of the node taken. If there is no priority information in the subsequent node information, each node can be taken in any order to check whether the injection satisfies all the constraints of the node taken.
本发明实施例为接种者推荐一系在推荐日期范 ί簡 1211内所需的未来的接种 的一个方法, 这一方法可以用于步骤 1216推荐一系的未来接种, 如果推荐该系 的未来接种不用到该系的 ISG的终结点或虽用到该系的 ISG的终结点但该终结 点没有可选接种 218约束条件, 所述方法有下列步骤- a) 如果在后续结点集合 1125中尚有未曾用于推荐的结点, 则在集合 1125 中取 τ一未曾用于推荐的结点; 否则结束本系推荐处理;  Embodiments of the present invention provide a method for a vaccinator to recommend a future vaccination required within the recommended date of the model, which may be used in step 1216 to recommend a future vaccination of a line, if a future vaccination of the line is recommended There is no need to go to the termination point of the ISG of the system or to use the termination point of the ISG of the system but there is no optional vaccination constraint 218. The method has the following steps - a) if in the subsequent node set 1125 If there is a node that has not been used for recommendation, then in the set 1125, τ is used for the recommended node; otherwise, the recommended processing is ended;
b) 使用推荐日期范围 1121 [Tstart,Tead]及接种者信息检验该结点的约束条件 204中的各约束条件是否满足: 如果满足, 则继续抉行 c): 否则转去 a); b) Use the recommended date range 1121 [T start , T ead ] and the vaccinator information to check whether the constraints in the constraint 204 of the node are satisfied: If yes, continue to c): otherwise go to a);
c)确定推荐日期范围 [Τ^,Τ^Ι及该结点的与时间范围有关的约束条件的交 集 ri :rrt] ,生成一个未来接种包含该结点的疫苗约束条件所确定的元疫苗及该时 间交集 [Trf,Tri], 记录此未来接种在推荐接种 1126中; 转去 a)。 c) determining the recommended date range [Τ^,Τ^Ι and the intersection of the constraints of the node with respect to the time range ri :r rt ], generating a meta-vaccination determined by future vaccination of vaccine constraints containing the node And then Intersection [T rf ,T ri ], record this future vaccination in the recommended inoculation 1126; transfer to a).
在上述方法中, 步骤 b)中, 检验与时间范围有关的约束条件的方法可以是 确定 [Τ^,Τ^}及该结点的与时间范围有关的约束条件的交集[ ,¾, 并判断该 交集是否为空。 与时间范 有关的约束条件主要是: 许可有效 期范围 220、 有 效日期范围 221、 年龄范围 219、 出生 0期范围, 以及推荐年龄范围、 推荐时间 间距、最小时间间距 I等对接种 间有限制的约束条件; 如果该时间交集 [ ΤΛ] 非空, 则与时间范 有关的约束条件满足, 否则不满足。 如在步骤 b)中已经确 定了上述时间交集 [Trf,Tn], 则在步骤 c)中可使用该值。 如果推荐年龄范围、 推 荐 间间距约束条件导致该交集 [Trf,Trt]为空, 则也可考虑采用最小年龄范围、最 小时间间距约束条件再次确定该交集[ 1¾ 是否为空,而不使用推荐年龄范围、 推荐时间间距约束条件;这种情况下得到的推荐接种应记录其是采用最小年龄范 围、 最小时间间距等条件生成的。 In the above method, in step b), the method of checking the constraint condition related to the time range may be determining [Τ^, Τ^} and the intersection of the time-range constraint conditions of the node [, 3⁄4, and judging Whether the intersection is empty. The constraints related to the time range are mainly: License validity period range 220, effective date range 221, age range 219, birth period 0 range, and recommended age range, recommended time interval, minimum time interval I, etc. Condition; if the time intersection [ Τ Λ ] is not empty, the constraint related to the time norm is satisfied, otherwise it is not satisfied. If the above time intersection [T rf , T n ] has been determined in step b), then this value can be used in step c). If the recommended age range and recommended spacing constraints result in the intersection [T rf , T rt ] being empty, then it is also considered to use the minimum age range and minimum time interval constraints to determine again the intersection [ 13⁄4 is empty, without using Recommended age range, recommended time interval constraints; recommended vaccination in this case should be recorded using minimum age range, minimum time interval and other conditions.
上述为接种者推荐一系的未来接种方法不能用有可选接种 2】8约束条件的 终结点来进行推荐; 当一系的 ISG的终结点有可选接种 218约束条件、 且该终 结点也应被选择用于该系推荐时, 应该使用下面的方法。  The above-mentioned future inoculation method recommended for the vaccinator cannot be recommended by the endpoint with the optional vaccination 2;8 constraint; when the termination of the ISG is optional, the 218 constraint is available, and the endpoint is also The following method should be used when it should be selected for the department's recommendation.
本发明的另一实施倒, 当一系的 ISG的终结点有可选接种 218约束条件、 ϋ该终结点被选择用于本系推荐时, 为接种者推荐一系在推荐日期范 i簡 1121内 所需的未来的接种的一个方法为:首先使用接种者信息检验该终结点的可选接种 218约束条件是否满足; 如满足, 则按无可选接种 218约束条件的终结点处理、 继续使 该终结点用于本系推荐; 如不满足, 设置该系的结束标识符 1127表示 该系的免疫接种已完成, 结束本系推荐处理。  In another implementation of the present invention, when the termination point of a series of ISGs has an optional vaccination 218 constraint, and the endpoint is selected for recommendation by the department, a recommendation is made for the vaccinator on the recommended date. One method of future vaccination required is to first use the vaccinator information to check if the optional vaccination 218 constraint for the endpoint is met; if satisfied, the endpoint is processed without the optional vaccination 218 constraint, continue to This endpoint is used for the recommendation of the department; if not, the end identifier 1127 of the system is set to indicate that the immunization of the system has been completed, and the recommendation process is terminated.
推荐的未来接种依赖于推荐 0期范围 1121及可用作推荐的结点, 因此推荐 的未来接种可能包含多个疫苗及不同的接种时间段。要缩小其范 ί簡可以使用一些 其他条件,例如使用优先级来确定各结点在被用于推荐时的取舍或优先次序, 以 及限定较窄的推荐日期范围 1121等。  The recommended future vaccination depends on the recommended phase 0 range 1121 and can be used as a recommended node, so the recommended future vaccination may include multiple vaccines and different vaccination periods. To narrow down the specification, some other conditions can be used, such as using priority to determine the trade-off or prioritization of each node when it is used for recommendation, and defining a narrower recommended date range 1121, and so on.
本发明另 ·实施例使 一系的截止年龄 Ατ优化一系的处理的一个方法如 下- 在如图〗0b)所描述的处理方法中的步骤】211后及步骤 1212前,先检验接种 者年龄是否己超过截止年龄 Αΐ; 超过则该接种者巳无需该系接种, 可以退出该 系的处理; 否则仍需处理这一系, 飼如执行步骤】212。 这一方法适用于只需要 未来接种推荐处理的客户, 其优点是可以节省处理时间, 明确接种者已无需该系 接种。缺点是这一方法无法给出对该系的评估。对于需要对接种史进行评估处理 的客户, 可以使 下面的方法。 Another embodiment of the present invention provides a method for optimizing the cut-off age Α τ of a series as follows - after the steps in the processing method described in FIG. 0b), after the step 211 and before the step 1212, the inoculator is first tested. Whether the age has exceeded the cut-off age ΐ ΐ; if the vaccination does not need the vaccination, the vaccination can withdraw from the department; otherwise, the system still needs to be treated, and the feeding step is as follows. This method is suitable for only need For customers who are recommended for future vaccination, the advantage is that they can save processing time and make it clear that the vaccinator does not need the vaccination. The disadvantage is that this method does not give an assessment of the system. For customers who need to evaluate the vaccination history, the following methods can be used.
本发明另一实施例使 ]¾一系的截止年龄 Ατ优化一系的处理的一个方法。在 如图 10b)所描述的处理方法中迸行推荐处理前,先检验接种者年龄是否已超过截 止年龄 AT, 超过则该接种者己无需该系接种, 可以退出该系的处理; 否则继续 推荐处理, 例如继续执行步骤】 216。 Another embodiment of the present invention provides a method for optimizing the processing of a series of cutoff ages Α τ . Before the recommended treatment in the treatment method as described in Fig. 10b), it is first checked whether the age of the vaccinator has exceeded the cut-off age A T , and if the vaccinator does not need the vaccination, the vaccination may withdraw from the treatment; otherwise, Recommended processing, for example, continue with the steps 216.
上述方法, 例如使用 ISG进行接种信息处理的方法、 预处理等方法, 可以 以计算机软件程序实现, 并组合成一个模块或架构的应用程序接口 (API) 以方 便使用。 倒如处理接种信息的方法或功能可以有应用程序接口函数 Report process(ClientInformation client), 这一函数接受接种者信息 Clientlnformation, 迸 行处理并返回处理的报告 Report。实现上述方法的^算机软件程序部署在计算机 可读媒介上,例如硬盘上, 在该程序的指令被加载入计算机的存储器中并被执行 时, 可以提供上述处理接种信息的方法的功能。  The above methods, such as methods for performing vaccination information processing using ISG, pre-processing, etc., can be implemented in a computer software program and combined into a module or architecture application program interface (API) for convenient use. For example, the method or function for processing the vaccination information may include an application interface function Report process (ClientInformation client), which accepts the vaccinator information Clientlnformation, processes and returns the processed report Report. The computer software program implementing the above method is deployed on a computer readable medium, such as a hard disk, and the functions of the method of processing the vaccination information described above can be provided when the instructions of the program are loaded into the memory of the computer and executed.
本发明的一个实施倒是当免疫程序改变^, 使用: SCAD更新 SG、 发行该 ISG 至使用 ISG处理接种信息的应用程序系统的一个方法, 该方法包括步骤:  One implementation of the present invention is a method of updating an SG, using: SCAD to update the SG, issuing the ISG, to an application system that processes the vaccination information using the ISG, the method comprising the steps of:
1 )在运行 ISCAD的系统上建立或更新 ISG、 以 XML文档文件格式出版发 行该 ISG;  1) Establish or update the ISG on the system running ISCAD, publish the ISG in the XML document file format;
2)传送该文档文件至运行使用 ISG的接种信息处理应 ]¾程序的系统, 如 通过使 磁盘、 USB盘、 局域网和互联网支持的文件传送方式, 倒如文件复制、 FTPS文件传送、 HTTPS文件上载下载等, 传送该文档至该应用程序系统的计算 机可读媒介;  2) Transfer the document file to a system that uses the ISG's vaccination information to process the program, such as file transfer via disk, USB disk, LAN, and Internet, such as file copy, FTPS file transfer, and HTTPS file upload. Downloading, etc., transferring the document to a computer readable medium of the application system;
3 ) 使该应用程序系统在处理接种信息时使用该文档所表示的 ISG。  3) Enable the application system to use the ISG represented by the document when processing the vaccination information.
虽然己经参照本发明实施倒对本发明在一定程度上进行了详细地描述, 但 是应该可以理解的是本发明实施例只是依例描述本发明,而不应视为对本发明的 限制。实际上本领域的普通技术人员可对上述技术方案在形式和细节上进行多种 修改、 省略和替代等改变而不脱离本发明的原理的范围。  Although the present invention has been described in detail with reference to the embodiments of the present invention, it should be understood that the present invention is not intended to limit the invention. Various modifications, omissions, and substitutions may be made in the form and the details of the invention without departing from the scope of the principles of the invention.

Claims

权 利 要 求  Rights request
L一种免疫程序图,其特征在于, 包括多个结点和多条矢线, L is an immune program map characterized by comprising a plurality of nodes and a plurality of vector lines,
a) 一个所述结点表示免疫程序的一剂次接种及其属性, 所述属性包括接种该剂次 接种的条件信息;  a) one of said nodes represents a dose of vaccination of the immunization program and its attributes, said attributes including conditional information for vaccination of the dose;
5 b) ·条所述矢线连接所述接种的结点和所述接种的一个下一剂次接种的结点, 矢 线指向所述的下一剂次接种的结点。  5 b) The bar is connected to the node of the inoculation and the node of the next inoculation of the inoculation, the vector pointing to the node of the next inoculation.
2.根据权利要求 1 所述的免疫程序图, 其特征在于, 采 以下数据结构存储免疫 程序图的一个结点及其后续结点的信息并能够用于接种信息处理- 所述数据结构包括以下数据元素; ( 1 ) 唯一地识别所述结点的识别符 (201 )、 ( 2 ) K) 所述结点所对应的一剂次接种的剂信息(202 ) 以及(3 )所述接种的下一剂次接种信息 后续结点信息 (203)。  2. The immune program map according to claim 1, wherein the following data structure stores information of a node of the immune program map and its subsequent nodes and can be used for vaccination information processing - the data structure includes the following a data element; (1) an identifier (201) that uniquely identifies the node, (2) K) a dose of the inoculated agent information corresponding to the node (202), and (3) the inoculated The next dose of vaccination information is followed by node information (203).
3. 根据权利要求 2所述的免疫程序图, 其特征在于, 所述剂信息包括一组约束条 件  3. The immune program map according to claim 2, wherein the agent information comprises a set of constraint conditions
4. 根据权利要求 3所述的免疫程序图, 其特征在于, 所述约束条件中的疫苗约束 15 条件是元疫苗的信息。 4. The immune program map according to claim 3, wherein the condition of the vaccine constraint in the constraint condition is information of a meta-vaccine.
5. 根据权利要求 3所述的免疫程序图, 其特征在于, 所述约束条件中包括有一个 结点的有效日期范围 (221 ) 的约束条件。  The immune program map according to claim 3, wherein the constraint includes a constraint condition of a valid date range (221) of the node.
6. 根据权利要求 2所述的免疫程序图, 其特征在于, 所述后续结点信息 (203 ) 包括每个后续结点的优先级信息。 6. The immune program map according to claim 2, wherein the subsequent node information (203) includes priority information of each subsequent node.
0 7. 一种生成及维护以免疫程序图组织的、 供接种信息处理使用的免疫程序的方 法, 其特征在于, 在计算机上提供图形用户界面, 使用户能够建立及维护如权利要求 1 - 6任一项所述的免疫程序图, 包括- 以图形方式建立、 编辑所述免疫程序图的结点及矢线:  0. A method of generating and maintaining an immunization program for use in vaccination information processing organized by an immunological schedule, characterized in that a graphical user interface is provided on a computer to enable a user to establish and maintain the claims 1 - 6 The immunological program diagram of any of the above, comprising: graphically establishing and editing a node and a vector line of the immune program map:
输入、 编辑所述免疫程序图中的结点的属性数据 (200)。 Enter and edit the attribute data (200) of the node in the immune program map.
5 8. 根据权利要求 7所述的生成及维护以免疫程序图组织的、 供接种信息处理使用 的免疫程序的方法, 其特征在于,所述 户界面包括一个基于免疫程序相关对象的动态 菜单和工具条生成和管理模块,用干生成和管理基于被选中的免疫程序相关对象的任务 菜单、 工具条, 以弓导用户建立、 维护及管理免疫程序图。 The method for generating and maintaining an immune program for use in vaccination information processing organized by an immune program according to claim 7, wherein the user interface comprises a dynamic menu based on an object related to the immune program and Toolbar generation and management module for generating and managing tasks based on selected immune program related objects Menus, toolbars, guide users to create, maintain and manage immune program maps.
9. 根据权利要求 8所述的生成及维护以免疫程序图组织的、 供接种信息处理使用 的免疫程序的方法, 其特征在于, 所述用户界面还包括免疫程序辅助设†任务模块, 用 于免疫程序图中相互关眹的数据的自动生成及完整、 自洽性的检验及维护。  9. The method of generating and maintaining an immune program for use in vaccination information processing organized by an immune program according to claim 8, wherein the user interface further comprises an immune program auxiliary setting task module, configured to: Automatic generation of data related to each other in the immune program map and complete, self-consistent inspection and maintenance.
10. 根据权利要求 9所述的生成及维护以免疫程序图组织的、 供接种信息处理使 用的免疫程序的方法, 其特征在于, 所述免疫程序辅助设计任务模块包括由疫苗生成元 疫苗的任务。  10. The method of generating and maintaining an immune program for use in vaccination information processing organized by an immune program according to claim 9, wherein said immune program assisted design task module comprises a task of generating a vaccine by a vaccine .
1丄 根据权利要求 9所述的生成及维护以免疫程序图组织的、 供接种信息处理使 用的免疫程序的方法, 其特征在于, 所述免疫程序辅助设计任务模块包括由疫苗或元疫 苗生成疫苗或元疫苗的免疫程序图框架的任务。  A method for generating and maintaining an immune program for use in vaccination information processing organized by an immune program according to claim 9, wherein said immune program assisted design task module comprises generating a vaccine from a vaccine or a meta-vaccine Or the task of the immune vaccine map framework of the meta-vaccine.
12. 根据权利要求 9所述的生成及维护以免疫程序图组织的、 供接种信息处理使 用的免疫程序的方法, 其特征在干, 所述免疫程序辅助设计任务模块包括分析一个结点 的后续结点间的约束条件重叠的任务;  12. The method of generating and maintaining an immune program for use in vaccination information processing organized by an immunological schedule according to claim 9, wherein said immune program assisted design task module comprises analyzing a follow-up of a node The task of overlapping constraints between nodes;
判断两结点约束条件没有重叠的判据是:比较两结点的相同的约束条件的参数值范 , 如果存在两结点任一相同约束条件的参数值是完全相斥的, 则该两结点没有重叠。  The criterion for judging that the two node constraints do not overlap is: comparing the parameter values of the same constraint of the two nodes, if there are two nodes with the same constraint, the parameter values are completely repulsive, then the two knots The points do not overlap.
13. 根据权利要求 7所述的生成及维护以免疫程序图组织的、 供接种信息处理使 用的免疫程序的方法, 其特征在于, 还包括在该^算机上, 发行建立及维护的免疫程序 图。  13. The method for generating and maintaining an immune program for use in vaccination information processing organized by an immune program according to claim 7, further comprising: issuing an immune program map for establishing and maintaining on the computer .
14。 根据权利要求 13所述的生成及维护以免疫程序图组织的、供接种信息处理使 用的免疫程序的方法, 其特征在于, 所述的发行建立及维护的的免疫程序图是指以图形 格式发行免疫程序图, 包括- a) 多个免疫程序框图, 所述免疫程序框图中的一个结点表对应于所述建立的免疫 程序图的一个结点, 所述结点表用于显示所述结点的约束条件; 及  14. The method for generating and maintaining an immunization program for use in vaccination information processing organized by an immunological program according to claim 13, wherein said immunization schedule for establishing and maintaining said distribution is in a graphic format An immunological program diagram comprising - a) a plurality of immune program block diagrams, a node table in the immune program block diagram corresponding to a node of the established immune program map, the node table being used to display the node Point constraint; and
b) 一个图例 ffi于说明所述免疫程序框图中各符号、 字符、 字符串、 图形元素的含 人、  b) a legend ffi to illustrate the inclusion of symbols, characters, strings, graphic elements in the immune block diagram,
15。 一种处理接种信息的方法, 其特征在于, 所述方法中使用到的免疫程序基于 杈利要求 1-6任一项所述的免疫程序图,所述免疫程序图的关干疫苗的信息是用元疫苗 信息,所述方法包括以下步骤; 15. A method for processing vaccination information, characterized in that the immunization program used in the method is based on the immunological program diagram according to any one of claims 1-6, and the information of the vaccination vaccine of the immunization program map is Meta-vaccine Information, the method comprising the following steps;
a) 初始化过程状态 Q I00 );  a) initialization process state Q I00 );
b) 预处理, 包括  b) pre-processing, including
将接种者的接种史中的各次注射转换成元疫苗注射、 并存储于系接种史 (1124) 中;  Each injection in the vaccination history of the vaccinator is converted into a vaccination injection and stored in the vaccination history (1124);
检验含减毒灭活疫苗的元疫苗注射间的 间间隔是否符合免疫程序规定, 不符合 的元疫苗注射是无效接种并被记录:  Check whether the interval between the vaccination doses containing the attenuated inactivated vaccine complies with the immunization program, and the non-conforming vaccination is invalid vaccination and recorded:
c) 逐系评估推荐处理- d) 后处理, 包括  c) follow-up evaluation recommendation processing - d) post-processing, including
检查推荐接种 (1 126 ) 中各含减毒灭活疫苗的接种间的时间间隔及与接种史中各 含减毒灭活疫苗的注射间的时间间隔是否符合免疫程序的规定;其中时间间隔不符合的 推荐接种将被调整,使其接种时间与其它含减毒灭活疫苗的推荐接种或注射的时间间隔 符合免疫程序的规定;  Check whether the time interval between the vaccination containing the attenuated inactivated vaccine in the recommended vaccination (1 126) and the time interval between the injections containing the attenuated inactivated vaccine in the vaccination history are in accordance with the immunization procedures; The recommended recommended vaccination will be adjusted so that the time between vaccination and other recommended vaccinations or injections containing the attenuated inactivated vaccine is in accordance with the immunization schedule;
转换推荐的未来接种中的元疫苗接种到疫苗接种:  Convert the recommended vaccination in the future vaccination to the vaccination:
生成处理报告。  Generate a processing report.
16, 根据权利要求 15所述的处理接种信息的方法, 其特征在于, 逐系评估推荐处 理的歩骤中对一系的处理方法为;  The method for processing vaccination information according to claim 15, wherein the processing method for evaluating the recommendation process in the step of evaluating the recommendation process is;
a) 初始化后续结点集合 (1Λ25 ), 将所述系的所有始结点的集合赋给所述后续结 点集合;  a) initializing a subsequent node set (1Λ25), assigning a set of all the initial nodes of the system to the subsequent node set;
b) 如接种者有所述系的接种史, 则评估所述系接种史;  b) assessing the history of vaccination if the vaccinator has a history of vaccination of the line;
c) 如接种者的所述系的免疫接种尚未完成, 则推荐所述系未来接种。  c) If the immunization of the line of the vaccinator has not been completed, the future vaccination is recommended.
17. 根据权利要求 16所述的处理接种信息的方法, 其特征在于, 评估所述系接种 史的 ·个方法为- a) 如果所述系接种史中尚有未评估的注射, 则在所述接种史中依注射时间先后取 下一未评估注射; 否则所述系评估结束, 退出所述系评估处理;  17. The method of processing vaccination information according to claim 16, wherein the method of evaluating the vaccination history is - a) if there is an unevaluated injection in the vaccination history, In the history of vaccination, the next unevaluated injection is taken according to the injection time; otherwise, the evaluation ends, and the evaluation process is withdrawn;
b )检验接种者个人信息及所述未评估接种是否满足后续结点集合 (1125 ) 中的某 一个结点的所有约束条件; 如果满足, 则所述注射为有效接种, 执行 c ) ; 否则转去执 行 a); b) checking the vaccinator's personal information and whether the unevaluated vaccination satisfies all the constraints of one of the subsequent node sets (1125); if satisfied, the injection is a valid vaccination, c) ; otherwise Go to Line a);
c)检查所述有效接种所对应的结点是否是一个终结点; 如不是终结点, 则取所述 结点的所有后续结点并赋给后续结点集合 (1 125), 转去 ¾行 a): 否剡置位所述系的结 束标识符为已完成, 退出所述系评估。  c) checking whether the node corresponding to the valid vaccination is an end point; if not the end point, taking all subsequent nodes of the node and assigning it to the subsequent node set (1 125), and switching to the 3⁄4 line a): Otherwise, the end identifier of the system is set to complete, exiting the system assessment.
18, 根据权利要求 16所述的处理接种信息的方法, 其特征在于, 所述推荐一系未 来接种是指确定在推荐日期范圈 [Tstart, TenJ内一系的未来接种、 且推荐该系的未来接种 不 到该系的免疫程序图的终结点或虽用到该系的免疫程序图的终结点但该终结点没 有可选接种 (218) 约束条件, 所述方法包括以下步骤- a) 如果在后续结点集合 (1125) 中尚有未曾用于推荐的结点, 则在所述集合中取 下一未曾用于推荐的结点; 否则结束本系推荐处理; The method for processing vaccination information according to claim 16, wherein the recommending a system of future vaccination refers to determining a future vaccination in the recommended date range [T start , T en J , and recommending The future inoculation of the line is not at the end of the line's immune program map or although the endpoint of the line's immune program map is used but there is no optional inoculation (218) constraint at the end point, the method includes the following steps - a) If there are still nodes in the subsequent node set (1125) that have not been used for recommendation, take the node that has not been used for recommendation in the set; otherwise, end the recommendation process;
b) 使用所述推荐日期范围 [Tstart, TS„J及接种者个人信息检验所述结点的约束条件 ( 204) 中的各约束条件是否满足; 如不满足, 则转去 a) ; b) using the recommended date range [T start , T S „J and the vaccinator personal information to check whether the constraints in the constraint (204) of the node are satisfied; if not, then a);
c)确定 [T ti J及所述结点的与时间范围有关的约束条件的交集 [TTf, Tj , 生成 一个未来接种包含所述结点的疫苗约束条件所确定的元疫苗及所述交集 TrJ, 记录 所述未来接种; 转去 a)。 c) determining [T ti J and the intersection of the time-range constraints associated with the node [T Tf , Tj , generating a meta-vaccine determined by the vaccine constraint containing the node in future vaccination and the intersection T r J, record the future vaccination; turn to a).
19. 根据权利要求 16所述的处理接种信息的方法, 其特征在于, 所述推荐一系未 来接种是指确定在推荐日期范围 [Ts;a t, Teil(1]内一系的未来接种,推荐该系的未来接种时 要用到该系的免疫接种图的终结点, 该终结点包含有可选接种约束条件时, 歩骤为: 首先检验所述可选接种约束条件是否满足; 如满足, 则按无可选接种约束条件的 终结点继续推荐处理; 否则所述系的免疫接种己完成, 结束所述系推荐处理。 19. The method of processing vaccination information according to claim 16, wherein said recommending a future vaccination means determining a future vaccination within a recommended date range [T s; at , T eil (1 ] It is recommended that the department's future vaccination should use the end point of the vaccination map of the department. When the endpoint contains optional vaccination constraints, the steps are as follows: First, check whether the optional vaccination constraints are met; If it is satisfied, the recommendation process is continued according to the endpoint without the optional vaccination constraint; otherwise, the immunization of the system is completed, and the recommended treatment is ended.
20. 一种系统, 包括: 用于 ¾行如权利要求 7所述的方法的各步骤的装置。 20. A system comprising: means for performing the steps of the method of claim 7.
21. 一种系统, 包括: 用于执行如权利要求 15所述的方法的各歩骤的装置21. A system comprising: means for performing the steps of the method of claim 15
22.—种系统, 包括: ]¾于执行如权利要求 8-14任一项或 16-19中的任一权利要 求所述的方法的各步骤的装置。 22. A system comprising: means for performing the steps of the method of any of claims 8-14 or 16-19.
PCT/CN2012/083567 2011-12-06 2012-10-26 Immunization procedure graph and building method therefor and inoculation information processing method and system WO2013082978A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2011104003908A CN102567571A (en) 2011-12-06 2011-12-06 Immunization program diagraph and building method thereof, inoculation information processing method and system for realizing same
CN201110400390.8 2011-12-06

Publications (1)

Publication Number Publication Date
WO2013082978A1 true WO2013082978A1 (en) 2013-06-13

Family

ID=46412964

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2012/083567 WO2013082978A1 (en) 2011-12-06 2012-10-26 Immunization procedure graph and building method therefor and inoculation information processing method and system

Country Status (2)

Country Link
CN (1) CN102567571A (en)
WO (1) WO2013082978A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102567571A (en) * 2011-12-06 2012-07-11 吴卫民 Immunization program diagraph and building method thereof, inoculation information processing method and system for realizing same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1659562A (en) * 2002-04-12 2005-08-24 贝克顿·迪金森公司 System for collecting storing presenting and analyzing immunization data having remote stations in communication with a vaccine and disease database over a network
CN101763422A (en) * 2010-01-12 2010-06-30 北京国信慧通科技有限责任公司 Method for storing vector data and indexing space
CN102567571A (en) * 2011-12-06 2012-07-11 吴卫民 Immunization program diagraph and building method thereof, inoculation information processing method and system for realizing same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1659562A (en) * 2002-04-12 2005-08-24 贝克顿·迪金森公司 System for collecting storing presenting and analyzing immunization data having remote stations in communication with a vaccine and disease database over a network
CN101763422A (en) * 2010-01-12 2010-06-30 北京国信慧通科技有限责任公司 Method for storing vector data and indexing space
CN102567571A (en) * 2011-12-06 2012-07-11 吴卫民 Immunization program diagraph and building method thereof, inoculation information processing method and system for realizing same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Prevention and vaccination of children flowchart", SOURCEJLINR LIVER DISEASE HOSPITAL, 16 October 2009 (2009-10-16), Retrieved from the Internet <URL:www.gb206.com/gbzg/yg/ygym/3958.html> *
ZHAO, HONG ET AL.: "An XML-based electronic medical record data storage strategy", ENTERPRISE TECHNOLOGY DEVELOPMENT, vol. 26, no. 4, April 2007 (2007-04-01), pages 25 - 27 *

Also Published As

Publication number Publication date
CN102567571A (en) 2012-07-11

Similar Documents

Publication Publication Date Title
US8983990B2 (en) Enforcing query policies over resource description framework data
US20160004759A1 (en) Platform for Managing and Visualizing Data on a Computer
Brunette et al. Open data kit 2.0: expanding and refining information services for developing regions
US9712551B2 (en) Methods and systems for architecture-centric threat modeling, analysis and visualization
CN103631852B (en) Method and system of context-based graph-relational intersect derived database
Blouin et al. Modeling model slicers
US11568288B2 (en) Augmented knowledge base and reasoning with uncertainties and/or incompleteness
US11443054B2 (en) Referenced access control list
TW201227519A (en) Converting desktop applications to web applications
US20150127375A1 (en) Methods and systems for cloud-based medical database management
KR20170098854A (en) Building reports
US20180121809A1 (en) Tree structured data transform
US11276484B1 (en) Clinical activity network generation
US10937529B2 (en) Family tree construction supporting method and family tree construction supporting device
Sakizloglou et al. Towards highly scalable runtime models with history
Paton et al. The role of free/libre and open source software in learning health systems
WO2013082978A1 (en) Immunization procedure graph and building method therefor and inoculation information processing method and system
Jamil Designing integrated computational biology pipelines visually
CN104808970B (en) A kind of method and system for realizing internationalized software
US9122985B2 (en) Programmatic access to terminologies expressed in hierarchical form
JP5490632B2 (en) Diagnostic report search device
Alebrahim et al. Optimizing functional and quality requirements according to stakeholders’ goals
JP2023504637A (en) Systems and methods for ETL pipelining
JP5867208B2 (en) Data model conversion program, data model conversion method, and data model conversion apparatus
CN117038002B (en) Method and device for generating observation variable in drug evaluation research

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12855093

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12855093

Country of ref document: EP

Kind code of ref document: A1